Sandbox:Hannan: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
'''Abbreviations'''
'''Abbreviations'''


ACTH: Adrenocorticotropic hormone, ARR: Aldosterone-renin ratio, CAM: Cellular adhesion molecules, ESR: Erythrocyte sedimentation rate, CT: Computerized tomography, Fluorescence in situ hybridization, FDG: Fluorodeoxyglucose, FSH: Follicle stimulating hormone, GI: Gastrointestinal, H&E stain: Hematoxylin and eosin stain,  
ACTH: Adrenocorticotropic hormone, ARR: Aldosterone-renin ratio, CAM: Cellular adhesion molecules, ERCP: Endoscopic retrograde cholangiopancreatography, ESR: Erythrocyte sedimentation rate, CT: Computerized tomography, Fluorescence in situ hybridization, FDG: Fluorodeoxyglucose, FSH: Follicle stimulating hormone, GI: Gastrointestinal, H&E stain: Hematoxylin and eosin stain, LCA: Leukocyte common antigen, LDH: Lactate dehydrogenase, LH: Luteinizing hormone, MEN: Multiple endocrine neoplasia, MRCP: Magnetic resonance cholangiopancreatography, MRI: Magnetic resonance imaging, N/A: Not applicable/Not available, N/L: Normal, PAS stain: Periodic acid–Schiff stain, PET: Position emission tomography, PGP: Protein gene product 9.5, TB: Tuberculosis, U/S: Ultrasound, ZF: Zona fasciculata, ZG: Zona granulosa, ZR: Zona reticularis.
{| class="wikitable"
{| class="wikitable"
|+
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Adrenal Cortex
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Cortex
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Dianosis
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Gold
standard
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
Line 16: Line 13:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|-
|-
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adrenal adenoma|Adenoma]]
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Adrenal [[Adrenal adenoma|Adenoma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aldosterone]]<ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid25958045">{{cite journal |vauthors=Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P |title=Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas |journal=Mol. Cell. Endocrinol. |volume=411 |issue= |pages=146–54 |date=August 2015 |pmid=25958045 |pmc=4474471 |doi=10.1016/j.mce.2015.04.022 |url=}}</ref><ref name="pmid20498828">{{cite journal |vauthors=Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD |title=Laboratory investigation of primary aldosteronism |journal=Clin Biochem Rev |volume=31 |issue=2 |pages=39–56 |date=May 2010 |pmid=20498828 |pmc=2874431 |doi= |url=}}</ref><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aldosterone]]<br><ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid25958045">{{cite journal |vauthors=Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P |title=Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas |journal=Mol. Cell. Endocrinol. |volume=411 |issue= |pages=146–54 |date=August 2015 |pmid=25958045 |pmc=4474471 |doi=10.1016/j.mce.2015.04.022 |url=}}</ref><ref name="pmid20498828">{{cite journal |vauthors=Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD |title=Laboratory investigation of primary aldosteronism |journal=Clin Biochem Rev |volume=31 |issue=2 |pages=39–56 |date=May 2010 |pmid=20498828 |pmc=2874431 |doi= |url=}}</ref><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref>
|
|
* [[Headache]]
* [[Headache]]
Line 48: Line 48:
** [[Zona reticularis|ZR]] (lipid-sparse [[cytoplasm]])
** [[Zona reticularis|ZR]] (lipid-sparse [[cytoplasm]])
|
|
* [[Adrenal]] [[mass]] or [[nodule]]
* [[Fludrocortisone]] suppression testing (Gold standard)
* Unilateral or bilateral [[adrenal]] [[atrophy]]
* Hypodense [[mass]] ([[CT]])
* Iso and low [[FDG]] uptake compared with [[liver]] ([[FDG]] [[PET]]/[[CT]])
* Hyperintense on in-phase and hypointense on oppose-phase ([[MRI]])
|
* [[Fludrocortisone]] suppression testing
* Oral [[Sodium]] loading
* Oral [[Sodium]] loading
* [[Saline]] infusion testing
* [[Saline]] infusion testing
Line 64: Line 58:
*  
*  
|
|
* [[Fludrocortisone]] suppression testing
* [[Adrenal]] [[mass]] or [[nodule]]
|
* [[nodule|Adrenal]] [[mass]] or nodule
* [[nodule|Unilateral or bilateral]] [[adrenal]] [[atrophy]]
* [[nodule|Hypodense]] [[mass]]
|
* Iso and low [[FDG]] uptake compared with [[liver]]
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
|
* [[Glucocorticoid]]-Remediable [[Aldosteronism]] responds to [[glucocorticoids]]
* [[Glucocorticoid]]-Remediable [[Aldosteronism]] responds to [[glucocorticoids]]
* Higher [[cardiovascular]] and [[cerebrovascular]] [[morbidity]]
* Higher [[cardiovascular]] and [[cerebrovascular]] [[morbidity]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cortisol]]<ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid18493137">{{cite journal |vauthors=Stratakis CA |title=Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome) |journal=Endocr Dev |volume=13 |issue= |pages=117–32 |date=2008 |pmid=18493137 |pmc=3132884 |doi=10.1159/000134829 |url=}}</ref><ref name="pmid25871963">{{cite journal |vauthors=Zilbermint M, Stratakis CA |title=Protein kinase A defects and cortisol-producing adrenal tumors |journal=Curr Opin Endocrinol Diabetes Obes |volume=22 |issue=3 |pages=157–62 |date=June 2015 |pmid=25871963 |pmc=4560837 |doi=10.1097/MED.0000000000000149 |url=}}</ref><ref name="pmid29685132">{{cite journal |vauthors=Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J |title=ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures |journal=BMC Endocr Disord |volume=18 |issue=1 |pages=22 |date=April 2018 |pmid=29685132 |pmc=5913873 |doi=10.1186/s12902-018-0250-6 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cortisol]]<br><ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid18493137">{{cite journal |vauthors=Stratakis CA |title=Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome) |journal=Endocr Dev |volume=13 |issue= |pages=117–32 |date=2008 |pmid=18493137 |pmc=3132884 |doi=10.1159/000134829 |url=}}</ref><ref name="pmid25871963">{{cite journal |vauthors=Zilbermint M, Stratakis CA |title=Protein kinase A defects and cortisol-producing adrenal tumors |journal=Curr Opin Endocrinol Diabetes Obes |volume=22 |issue=3 |pages=157–62 |date=June 2015 |pmid=25871963 |pmc=4560837 |doi=10.1097/MED.0000000000000149 |url=}}</ref><ref name="pmid29685132">{{cite journal |vauthors=Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J |title=ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures |journal=BMC Endocr Disord |volume=18 |issue=1 |pages=22 |date=April 2018 |pmid=29685132 |pmc=5913873 |doi=10.1186/s12902-018-0250-6 |url=}}</ref>
|
|
* [[Weight]] gain
* [[Weight]] gain
Line 106: Line 108:
* Adjacent [[Atrophy|atrophied]] [[cells]]
* Adjacent [[Atrophy|atrophied]] [[cells]]
* [[Hemorrhage]] and [[calcification]] (Pre-[[malignant]] [[lesions]])
* [[Hemorrhage]] and [[calcification]] (Pre-[[malignant]] [[lesions]])
|
* [[Adrenal]] [[mass]] or [[nodule]]
* Unilateral or bilateral [[adrenal]] [[atrophy]]
* ↑ [[Fat]]
* Hypodense [[mass]] ([[CT]])
* Iso and low [[FDG]] uptake compared with [[liver]] ([[FDG]] [[PET]]/[[CT]])
* Hyperintense on in-phase and hypointense on oppose-phase ([[MRI]])
|
|
* Diurnal [[plasma]] [[cortisol]] variation
* Diurnal [[plasma]] [[cortisol]] variation
Line 122: Line 117:
* [[Dual energy X-ray absorptiometry|Dual-energy X-ray absorptiometry]]
* [[Dual energy X-ray absorptiometry|Dual-energy X-ray absorptiometry]]
|
|
* N/A
* [[Adrenal]] [[mass]] or [[nodule]]
* ↑ [[Fat]]
|
* [[Adrenal]] [[mass]] or [[nodule]]
* Unilateral or bilateral [[adrenal]] [[atrophy]]
* ↑ [[Fat]]
* Hypodense [[mass]]
|
* Iso and low [[FDG]] uptake compared with [[liver]]
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
|
* Associated with [[Carney complex]]
* Associated with [[Carney complex]]
Line 128: Line 133:
* [[Plasma]] levels of [[cortisol]] and [[ACTH]] may show false positive and false negative results due to normal diurnal [[hormonal]] variation
* [[Plasma]] levels of [[cortisol]] and [[ACTH]] may show false positive and false negative results due to normal diurnal [[hormonal]] variation
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Androgens]]<ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref><ref name="pmid16278716">{{cite journal |vauthors=Arnold DT, Reed JB, Burt K |title=Evaluation and management of the incidental adrenal mass |journal=Proc (Bayl Univ Med Cent) |volume=16 |issue=1 |pages=7–12 |date=January 2003 |pmid=16278716 |pmc=1200803 |doi= |url=}}</ref><ref name="pmid23819074">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J |title=Pure androgen-secreting adrenal adenoma associated with resistant hypertension |journal=Case Rep Endocrinol |volume=2013 |issue= |pages=356086 |date=2013 |pmid=23819074 |pmc=3681270 |doi=10.1155/2013/356086 |url=}}</ref><ref name="pmid30674304">{{cite journal |vauthors=Zhou WB, Chen N, Li CJ |title=A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman |journal=BMC Endocr Disord |volume=19 |issue=1 |pages=14 |date=January 2019 |pmid=30674304 |pmc=6343319 |doi=10.1186/s12902-019-0342-y |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Androgens]]<br><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref><ref name="pmid16278716">{{cite journal |vauthors=Arnold DT, Reed JB, Burt K |title=Evaluation and management of the incidental adrenal mass |journal=Proc (Bayl Univ Med Cent) |volume=16 |issue=1 |pages=7–12 |date=January 2003 |pmid=16278716 |pmc=1200803 |doi= |url=}}</ref><ref name="pmid23819074">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J |title=Pure androgen-secreting adrenal adenoma associated with resistant hypertension |journal=Case Rep Endocrinol |volume=2013 |issue= |pages=356086 |date=2013 |pmid=23819074 |pmc=3681270 |doi=10.1155/2013/356086 |url=}}</ref><ref name="pmid30674304">{{cite journal |vauthors=Zhou WB, Chen N, Li CJ |title=A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman |journal=BMC Endocr Disord |volume=19 |issue=1 |pages=14 |date=January 2019 |pmid=30674304 |pmc=6343319 |doi=10.1186/s12902-019-0342-y |url=}}</ref>
|
|
* [[Hirsutism]]
* [[Hirsutism]]
Line 156: Line 161:


*  
*  
|
* Well-defined
* Solid [[mass]]
* Homogeneous enhancement ([[CT]] [[contrast]])
* Hyperintense on in-phase and hypointense on oppose-phase ([[MRI]])
|
|
* [[FSH]], [[LH]], [[prolactin]] levels
* [[FSH]], [[LH]], [[prolactin]] levels
Line 168: Line 167:
* [[Pelvic]] [[Ultrasound]]
* [[Pelvic]] [[Ultrasound]]
* [[Adrenal Venous sampling]]
* [[Adrenal Venous sampling]]
|
* Well-defined
* Solid [[mass]]
|
* Homogeneous enhancement ([[CT]] [[contrast]])
|
|
* N/A
* N/A
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
|
* Extremely rare
* Extremely rare
* Most [[androgen]] secreting [[adenomas]] are mixed [[tumors]]
* Most [[androgen]] secreting [[adenomas]] are mixed [[tumors]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Non-functional<ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid27479926">{{cite journal |vauthors=Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A |title="Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study |journal=Ann. Intern. Med. |volume=165 |issue=8 |pages=533–542 |date=October 2016 |pmid=27479926 |pmc=5453639 |doi=10.7326/M16-0547 |url=}}</ref><ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid23255953">{{cite journal |vauthors=Li B, Guo Q, Yang H, Guan J |title=Giant non-functional adrenal adenoma: A case report |journal=Oncol Lett |volume=5 |issue=1 |pages=378–380 |date=January 2013 |pmid=23255953 |pmc=3525484 |doi=10.3892/ol.2012.978 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Non-functional<br><ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |doi=10.1259/bjr.20151018 |url=}}</ref><ref name="pmid27479926">{{cite journal |vauthors=Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A |title="Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study |journal=Ann. Intern. Med. |volume=165 |issue=8 |pages=533–542 |date=October 2016 |pmid=27479926 |pmc=5453639 |doi=10.7326/M16-0547 |url=}}</ref><ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid23255953">{{cite journal |vauthors=Li B, Guo Q, Yang H, Guan J |title=Giant non-functional adrenal adenoma: A case report |journal=Oncol Lett |volume=5 |issue=1 |pages=378–380 |date=January 2013 |pmid=23255953 |pmc=3525484 |doi=10.3892/ol.2012.978 |url=}}</ref>
|
|
* Asymptomatic
* Asymptomatic
Line 200: Line 206:
* Typically resemble normal [[adrenal]] [[histology]]
* Typically resemble normal [[adrenal]] [[histology]]
* May see [[hemorrhage]] & [[necrosis]]
* May see [[hemorrhage]] & [[necrosis]]
|
* Solid, well defined [[mass]] ([[ultrasound]])
* High [[lipid]] content and adjacent compression ([[CT]])
* Hyperintense on in-phase and hypointense on oppose-phase ([[MRI]])
|
|
* [[Adrenal]] [[hormones]] levels
* [[Adrenal]] [[hormones]] levels
Line 210: Line 212:
* ARR
* ARR
* [[Immunohistochemical staining]]
* [[Immunohistochemical staining]]
|
* Solid, well defined [[mass]]
|
* High [[lipid]] content and adjacent compression
|
|
* N/A
* N/A
|
* Hyperintense on in-phase and hypointense on oppose-phase
|
|
* 2-fold increased risk for [[Diabetes mellitus]] in some studies
* 2-fold increased risk for [[Diabetes mellitus]] in some studies
* Work up must exclude [[Cushing syndrome]], [[pheochromocytoma]] and [[adrenal carcinoma]]
* Work up must exclude [[Cushing syndrome]], [[pheochromocytoma]] and [[adrenal carcinoma]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adrenal cancer|Carcinoma]]<ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid26191527">{{cite journal |vauthors=Libé R |title=Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment |journal=Front Cell Dev Biol |volume=3 |issue= |pages=45 |date=2015 |pmid=26191527 |pmc=4490795 |doi=10.3389/fcell.2015.00045 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid24423978">{{cite journal |vauthors=Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD |title=Adrenocortical carcinoma |journal=Endocr. Rev. |volume=35 |issue=2 |pages=282–326 |date=April 2014 |pmid=24423978 |pmc=3963263 |doi=10.1210/er.2013-1029 |url=}}</ref><ref name="pmid24102952">{{cite journal |vauthors=Wang C, Sun Y, Wu H, Zhao D, Chen J |title=Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers |journal=Histopathology |volume=64 |issue=4 |pages=567–76 |date=March 2014 |pmid=24102952 |pmc=4282325 |doi=10.1111/his.12283 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adrenal [[Adrenal cancer|Carcinoma]]<br><ref name="pmid20823463">{{cite journal |vauthors=Nieman LK |title=Approach to the patient with an adrenal incidentaloma |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4106–13 |date=September 2010 |pmid=20823463 |pmc=2936073 |doi=10.1210/jc.2010-0457 |url=}}</ref><ref name="pmid26191527">{{cite journal |vauthors=Libé R |title=Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment |journal=Front Cell Dev Biol |volume=3 |issue= |pages=45 |date=2015 |pmid=26191527 |pmc=4490795 |doi=10.3389/fcell.2015.00045 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid24423978">{{cite journal |vauthors=Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD |title=Adrenocortical carcinoma |journal=Endocr. Rev. |volume=35 |issue=2 |pages=282–326 |date=April 2014 |pmid=24423978 |pmc=3963263 |doi=10.1210/er.2013-1029 |url=}}</ref><ref name="pmid24102952">{{cite journal |vauthors=Wang C, Sun Y, Wu H, Zhao D, Chen J |title=Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers |journal=Histopathology |volume=64 |issue=4 |pages=567–76 |date=March 2014 |pmid=24102952 |pmc=4282325 |doi=10.1111/his.12283 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[Cortisol]]
* [[Cortisol]]
Line 242: Line 250:
* ↑ [[Blood]] [[glucose]]
* ↑ [[Blood]] [[glucose]]
|
|
* brown to orange to yellow
* Brown to orange to yellow
* [[Necrosis]] & [[mitosis]]
* [[Necrosis]] & [[mitosis]]
* [[Hypercellular]] & [[solid]] and/or diffuse [[growth]] pattern
* [[Hypercellular]] & [[solid]] and/or diffuse [[growth]] pattern
Line 248: Line 256:
* [[Nuclear]] [[pleomorphism]]
* [[Nuclear]] [[pleomorphism]]
* Lymphovascular [[invasion]]
* Lymphovascular [[invasion]]
|
* Heterogeneous enhancement ([[CT]])
* Heterogenous hyper-intensity (T2-weighted) and hypo-intensity on (T1-weighted) ([[MRI]])
* Heterogeneous mass with intense [[FDG]] uptake greater than [[liver]] ([<sup>18</sup>F][[FDG]] [[PET]]/[[CT]])
|
|
* [[Serum]] [[ACTH]]
* [[Serum]] [[ACTH]]
Line 261: Line 265:
|
|
* N/A
* N/A
|
* Heterogeneous enhancement
|
* Heterogeneous mass with intense [[FDG]] uptake greater than [[liver]]
|
* Heterogenous hyper-intensity (T2-weighted) and hypo-intensity on (T1-weighted)
|
|
* May cause [[hypoglycemia]] (Anderson's syndrome}
* May cause [[hypoglycemia]] (Anderson's syndrome}
* May be associated with:
* May be associated with:
** [[Hyperreninemic hypoaldosteronism|hyperreninemic]]
** [[Hyperreninemic hypoaldosteronism|Hyperreninemic]]
** [[hyperaldosteronism]]
** [[Hyperaldosteronism]]
** [[erythropoietin]]-associated [[polycythemia]]
** [[Erythropoietin]]-associated [[polycythemia]]
** [[leukocytosis]]
** [[Leukocytosis]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adrenal hyperplasia|Hyperplasia]]<ref name="pmid25958045">{{cite journal |vauthors=Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P |title=Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas |journal=Mol. Cell. Endocrinol. |volume=411 |issue= |pages=146–54 |date=August 2015 |pmid=25958045 |pmc=4474471 |doi=10.1016/j.mce.2015.04.022 |url=}}</ref><ref name="pmid18493137">{{cite journal |vauthors=Stratakis CA |title=Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome) |journal=Endocr Dev |volume=13 |issue= |pages=117–32 |date=2008 |pmid=18493137 |pmc=3132884 |doi=10.1159/000134829 |url=}}</ref><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref><ref name="pmid16278716">{{cite journal |vauthors=Arnold DT, Reed JB, Burt K |title=Evaluation and management of the incidental adrenal mass |journal=Proc (Bayl Univ Med Cent) |volume=16 |issue=1 |pages=7–12 |date=January 2003 |pmid=16278716 |pmc=1200803 |doi= |url=}}</ref><ref name="pmid23819074">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J |title=Pure androgen-secreting adrenal adenoma associated with resistant hypertension |journal=Case Rep Endocrinol |volume=2013 |issue= |pages=356086 |date=2013 |pmid=23819074 |pmc=3681270 |doi=10.1155/2013/356086 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28707538">{{cite journal |vauthors=Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM |title=Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics |journal=Br J Radiol |volume=90 |issue=1079 |pages=20170330 |date=November 2017 |pmid=28707538 |pmc=5963387 |doi=10.1259/bjr.20170330 |url=}}</ref><ref name="pmid26770569">{{cite journal |vauthors=Zhang Y, Li H |title=Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease |journal=Int J Clin Exp Med |volume=8 |issue=10 |pages=19311–7 |date=2015 |pmid=26770569 |pmc=4694469 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adrenal [[Adrenal hyperplasia|Hyperplasia]]<br><ref name="pmid25958045">{{cite journal |vauthors=Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P |title=Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas |journal=Mol. Cell. Endocrinol. |volume=411 |issue= |pages=146–54 |date=August 2015 |pmid=25958045 |pmc=4474471 |doi=10.1016/j.mce.2015.04.022 |url=}}</ref><ref name="pmid18493137">{{cite journal |vauthors=Stratakis CA |title=Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome) |journal=Endocr Dev |volume=13 |issue= |pages=117–32 |date=2008 |pmid=18493137 |pmc=3132884 |doi=10.1159/000134829 |url=}}</ref><ref name="pmid24605256">{{cite journal |vauthors=Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C |title=Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging |journal=J Clin Imaging Sci |volume=3 |issue= |pages=61 |date=2013 |pmid=24605256 |pmc=3935261 |doi=10.4103/2156-7514.124088 |url=}}</ref><ref name="pmid16278716">{{cite journal |vauthors=Arnold DT, Reed JB, Burt K |title=Evaluation and management of the incidental adrenal mass |journal=Proc (Bayl Univ Med Cent) |volume=16 |issue=1 |pages=7–12 |date=January 2003 |pmid=16278716 |pmc=1200803 |doi= |url=}}</ref><ref name="pmid23819074">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J |title=Pure androgen-secreting adrenal adenoma associated with resistant hypertension |journal=Case Rep Endocrinol |volume=2013 |issue= |pages=356086 |date=2013 |pmid=23819074 |pmc=3681270 |doi=10.1155/2013/356086 |url=}}</ref><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28707538">{{cite journal |vauthors=Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM |title=Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics |journal=Br J Radiol |volume=90 |issue=1079 |pages=20170330 |date=November 2017 |pmid=28707538 |pmc=5963387 |doi=10.1259/bjr.20170330 |url=}}</ref><ref name="pmid26770569">{{cite journal |vauthors=Zhang Y, Li H |title=Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease |journal=Int J Clin Exp Med |volume=8 |issue=10 |pages=19311–7 |date=2015 |pmid=26770569 |pmc=4694469 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[Cortisol]] (most common)
* [[Cortisol]] (most common)
Line 279: Line 289:
** [[Cushing syndrome]]
** [[Cushing syndrome]]
** [[Hyperaldosteronism]]
** [[Hyperaldosteronism]]
** [[Virilization]], [[hirsutism]], [[menstrual irregularities]], [[testicular]] [[atrophy]] & diminished [[libido]]  
** [[Virilization]]  
** [[Hirsutism]]  
** [[Menstrual irregularities]]  
** [[Testicular]] [[atrophy]]  
** Diminished [[libido]]  
* Localized [[symptoms]] such as [[abdominal]] [[pain]], [[mass]], [[fullness]], early [[satiety]]
* Localized [[symptoms]] such as [[abdominal]] [[pain]], [[mass]], [[fullness]], early [[satiety]]
|
|
Line 285: Line 299:
** [[Cushing syndrome]]
** [[Cushing syndrome]]
** [[Hyperaldosteronism]]
** [[Hyperaldosteronism]]
** [[Virilization]], [[hirsutism]], [[menstrual]] irregularities, [[gynaecomastia]] and [[testicular]] [[atrophy]]  
** [[Virilization]]  
* Localized [[signs]] such as [[abdominal]] [[mass]],[[abdominal]] distension
** [[Hirsutism]]  
** [[Menstrual irregularities]]  
** [[Testicular]] [[atrophy]]  
** [[Gynecomastia]]  
* Localized [[symptoms]] such as [[abdominal]] [[pain]], [[mass]], [[fullness]], early [[satiety]]
|
|
* ↑ [[Serum]] [[cortisol]]
* ↑ [[Serum]] [[cortisol]]
Line 298: Line 316:
* ↑ [[Serum]] [[androstenedione]]
* ↑ [[Serum]] [[androstenedione]]
* ↑ [[Serum]] [[dehydroepiandrosterone sulfate]] ([[DHEA-S]])
* ↑ [[Serum]] [[dehydroepiandrosterone sulfate]] ([[DHEA-S]])
* ↑ [[plasma]] and [[urine]] [[estrogens]]
* ↑ [[Plasma]] and [[urine]] [[estrogens]]
|
|


Line 308: Line 326:
* [[endocrine]] [[atypia]]
* [[endocrine]] [[atypia]]
* Small [[nodules]]  
* Small [[nodules]]  
|
* [[Adrenal]] [[mass]]
* Unilateral or bilateral [[adrenal]] enlargement or thickening
* [[Density]] and signaling is same as that of normal [[adrenal gland]]
|
|
* [[Adrenal venous sampling]]
* [[Adrenal venous sampling]]
Line 322: Line 336:
* [[FSH]], [[LH]], [[prolactin]] levels
* [[FSH]], [[LH]], [[prolactin]] levels
* [[Cortisol]] levels
* [[Cortisol]] levels
|
* [[Adrenal]] [[mass]]
* Unilateral or bilateral [[adrenal]] enlargement or thickening
|
* Unilateral or bilateral [[adrenal]] enlargement or thickening
* [[Density]] is same as that of normal [[adrenal gland]]
|
|
* N/A
* N/A
|
* Unilateral or bilateral [[adrenal]] enlargement or thickening
* Signaling is same as that of normal [[adrenal gland]]
|
|
* [[Congenital adrenal hyperplasia]] presents in [[children]]/young adults
* [[Congenital adrenal hyperplasia]] presents in [[children]]/young adults
Line 332: Line 355:
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Dianosis
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Gold
standard
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
Line 341: Line 362:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pheochromocytoma]]<ref name="pmid24636754">{{cite journal |vauthors=Martucci VL, Pacak K |title=Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment |journal=Curr Probl Cancer |volume=38 |issue=1 |pages=7–41 |date=2014 |pmid=24636754 |pmc=3992879 |doi=10.1016/j.currproblcancer.2014.01.001 |url=}}</ref><ref name="pmid20541673">{{cite journal |vauthors=Kantorovich V, Pacak K |title=Pheochromocytoma and paraganglioma |journal=Prog. Brain Res. |volume=182 |issue= |pages=343–73 |date=2010 |pmid=20541673 |pmc=4714594 |doi=10.1016/S0079-6123(10)82015-1 |url=}}</ref><ref name="pmid19605896">{{cite journal |vauthors=Miller AD, Masek-Hammerman K, Dalecki K, Mansfield KG, Westmoreland SV |title=Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus) |journal=Vet. Pathol. |volume=46 |issue=6 |pages=1221–9 |date=November 2009 |pmid=19605896 |doi=10.1354/vp.09-VP-0022-M-FL |url=}}</ref><ref name="pmid19120142">{{cite journal |vauthors=Kantorovich V, Eisenhofer G, Pacak K |title=Pheochromocytoma: an endocrine stress mimicking disorder |journal=Ann. N. Y. Acad. Sci. |volume=1148 |issue= |pages=462–8 |date=December 2008 |pmid=19120142 |pmc=2693284 |doi=10.1196/annals.1410.081 |url=}}</ref><ref name="pmid25332315">{{cite journal |vauthors=Eisenhofer G, Peitzsch M |title=Laboratory evaluation of pheochromocytoma and paraganglioma |journal=Clin. Chem. |volume=60 |issue=12 |pages=1486–99 |date=December 2014 |pmid=25332315 |doi=10.1373/clinchem.2014.224832 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pheochromocytoma]]<br><ref name="pmid24636754">{{cite journal |vauthors=Martucci VL, Pacak K |title=Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment |journal=Curr Probl Cancer |volume=38 |issue=1 |pages=7–41 |date=2014 |pmid=24636754 |pmc=3992879 |doi=10.1016/j.currproblcancer.2014.01.001 |url=}}</ref><ref name="pmid20541673">{{cite journal |vauthors=Kantorovich V, Pacak K |title=Pheochromocytoma and paraganglioma |journal=Prog. Brain Res. |volume=182 |issue= |pages=343–73 |date=2010 |pmid=20541673 |pmc=4714594 |doi=10.1016/S0079-6123(10)82015-1 |url=}}</ref><ref name="pmid19605896">{{cite journal |vauthors=Miller AD, Masek-Hammerman K, Dalecki K, Mansfield KG, Westmoreland SV |title=Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus) |journal=Vet. Pathol. |volume=46 |issue=6 |pages=1221–9 |date=November 2009 |pmid=19605896 |doi=10.1354/vp.09-VP-0022-M-FL |url=}}</ref><ref name="pmid19120142">{{cite journal |vauthors=Kantorovich V, Eisenhofer G, Pacak K |title=Pheochromocytoma: an endocrine stress mimicking disorder |journal=Ann. N. Y. Acad. Sci. |volume=1148 |issue= |pages=462–8 |date=December 2008 |pmid=19120142 |pmc=2693284 |doi=10.1196/annals.1410.081 |url=}}</ref><ref name="pmid25332315">{{cite journal |vauthors=Eisenhofer G, Peitzsch M |title=Laboratory evaluation of pheochromocytoma and paraganglioma |journal=Clin. Chem. |volume=60 |issue=12 |pages=1486–99 |date=December 2014 |pmid=25332315 |doi=10.1373/clinchem.2014.224832 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[catecholamines]]
* [[Catecholamines]]
|
|
*[[Headaches]]
*[[Headaches]]
Line 374: Line 398:
*[[Psychosis]]
*[[Psychosis]]
|
|
* ↑ [[Plasma]] and [[urine]] [[catecholamines]]
* ↑ [[Plasma]] and [[urine]] [[catecholamines]] (Gold standard)
* ↑ [[Plasma]] and [[urine]] [[metanephrines]]
* ↑ [[Plasma]] and [[urine]] [[metanephrines]] (Gold standard)
* ↑ [[Chromogranin A]]
* ↑ [[Chromogranin A]]
* ↑ [[Plasma]] [[methoxytyramine]]
* ↑ [[Plasma]] [[methoxytyramine]]
Line 382: Line 406:
*Scattered [[tumor]] [[cells]] with prominent anisokaryosis, abundant [[eosinophilic]] granular [[cytoplasm]] and indistinct [[cell]] borders
*Scattered [[tumor]] [[cells]] with prominent anisokaryosis, abundant [[eosinophilic]] granular [[cytoplasm]] and indistinct [[cell]] borders
*Occasional bi-nucleate [[cells]]
*Occasional bi-nucleate [[cells]]
|
*Heterogeneous appearance, often with some [[cystic]] areas. [[Calcification]] or [[hemorrhage]] may also be present ([[CT-scans|CT]])
*T2-bright lesions, with/without [[cystic]] or [[necrotic]] components ([[MRI]])
*[[Cystic]] or solid with [[necrotic]] areas or [[hemorrhages]] ([[Ultrasonogram|U/S]])
|
|
*Genetic testing
*Genetic testing
Line 395: Line 414:
*[[Octereoscan]]
*[[Octereoscan]]
|
|
* [[Plasma]] and [[urine]] [[catecholamines]] & [[metanephrines]] combined with [[clinical]] findings
*[[Cystic]] or solid with [[necrotic]] areas or [[hemorrhages]]
|
* Heterogeneous appearance, often with some [[cystic]] areas.
* [[Calcification]] or [[hemorrhage]] may also be present
|
* N/A
|
* T2-bright lesions, with/without [[cystic]] or [[necrotic]] components
|
|
*May mimic [[panic attack]]
*May mimic [[panic attack]]
*May be associated with  [[Von Hippel-Lindau disease]],  [[MEN type 2]] and [[Neurofibromatosis type 1]].
*May be associated with  [[Von Hippel-Lindau disease]],  [[MEN type 2]] and [[neurofibromatosis type 1]].
*Arise from the [[chromaffin cells]]
*Arise from the [[chromaffin cells]]
*[[Stain|Stains]] positive for
*[[Stain|Stains]] positive for
Line 407: Line 433:
** [[Glial fibrillary acidic protein]] ([[GFAP]])
** [[Glial fibrillary acidic protein]] ([[GFAP]])
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neuroblastoma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid25154816">{{cite journal |vauthors=Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG |title=Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project |journal=J. Clin. Oncol. |volume=32 |issue=28 |pages=3169–76 |date=October 2014 |pmid=25154816 |pmc=4171360 |doi=10.1200/JCO.2014.56.1621 |url=}}</ref><ref name="pmid25254086">{{cite journal |vauthors=Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S |title=Epidemiological and clinical characteristics of neuroblastoma in southern iran |journal=Iran J Ped Hematol Oncol |volume=4 |issue=3 |pages=89–96 |date=2014 |pmid=25254086 |pmc=4173027 |doi= |url=}}</ref><ref name="pmid24563879">{{cite journal |vauthors=Skoura E, Oikonomopoulos G, Vasileiou S, Kyprianou D, Koumakis G, Datseris IE |title=(18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma |journal=Hell J Nucl Med |volume=17 |issue=1 |pages=58–61 |date=2014 |pmid=24563879 |doi=10.1967/s002449910116 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neuroblastoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid25154816">{{cite journal |vauthors=Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG |title=Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project |journal=J. Clin. Oncol. |volume=32 |issue=28 |pages=3169–76 |date=October 2014 |pmid=25154816 |pmc=4171360 |doi=10.1200/JCO.2014.56.1621 |url=}}</ref><ref name="pmid25254086">{{cite journal |vauthors=Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S |title=Epidemiological and clinical characteristics of neuroblastoma in southern iran |journal=Iran J Ped Hematol Oncol |volume=4 |issue=3 |pages=89–96 |date=2014 |pmid=25254086 |pmc=4173027 |doi= |url=}}</ref><ref name="pmid24563879">{{cite journal |vauthors=Skoura E, Oikonomopoulos G, Vasileiou S, Kyprianou D, Koumakis G, Datseris IE |title=(18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma |journal=Hell J Nucl Med |volume=17 |issue=1 |pages=58–61 |date=2014 |pmid=24563879 |doi=10.1967/s002449910116 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[catecholamines]]
* [[Catecholamines]]
|
|
* Constitutional
* Constitutional
Line 437: Line 463:
* [[Thrombocytosis]]
* [[Thrombocytosis]]
|
|
* Pathological examinations are gold standard.
* Cells may show:
* Cells may show:
** Undifferentiation
** Undifferentiation
Line 443: Line 470:
* [[Necrosis]]
* [[Necrosis]]
* Salt and pepper [[chromatin]]
* Salt and pepper [[chromatin]]
* [[spindle]]-like [[fibers]]
* [[Spindle]]-like [[fibers]]
|
* Large mass extending across the midline      ([[CT]])
* Heterogeneous enhancement ([[CT]])
* [[Calcification]] & [[hemorrhage]] ([[CT]] & [[MRI]])
* Non-homogeneous and hyperintense (T2-weighted)
* Hypointense (T1-weighted)
|
|
* [[Immunohistochemical staining]]
* [[Immunohistochemical staining]]
Line 458: Line 479:
*[[Genetic testing]]
*[[Genetic testing]]
|
|
* Pathological examinations
* Large mass
|[[Stain|Stains]] positive for
* May cross midline
|
* Large mass extending across the midline
* Heterogeneous enhancement
* [[Calcification]] & [[hemorrhage]]
|
* N/A
|
* [[Calcification]] & [[hemorrhage]]
* Non-homogeneous and hyperintense
* Hypointense (T1-weighted)
|[[Stain|Stains]] positive for:
* [[Chromogranin A]] (CGA)
* [[Chromogranin A]] (CGA)
* Protein gene product (PGP) 9.5
* Protein gene product (PGP) 9.5
Line 469: Line 501:
*
*
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ganglioneuroma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid29085827">{{cite journal |vauthors=Mylonas KS, Schizas D, Economopoulos KP |title=Adrenal ganglioneuroma: What you need to know |journal=World J Clin Cases |volume=5 |issue=10 |pages=373–377 |date=October 2017 |pmid=29085827 |pmc=5648998 |doi=10.12998/wjcc.v5.i10.373 |url=}}</ref><ref name="pmid24779851">{{cite journal |vauthors=Adas M, Koc B, Adas G, Ozulker F, Aydin T |title=Ganglioneuroma presenting as an adrenal incidentaloma: a case report |journal=J Med Case Rep |volume=8 |issue= |pages=131 |date=April 2014 |pmid=24779851 |pmc=4031973 |doi=10.1186/1752-1947-8-131 |url=}}</ref><ref name="pmid23661526">{{cite journal |vauthors=Li J, Yang CH, Li LM |title=Diagnosis and treatment of 29 cases of adrenal ganglioneuroma |journal=Eur Rev Med Pharmacol Sci |volume=17 |issue=8 |pages=1110–3 |date=April 2013 |pmid=23661526 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ganglioneuroma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid29085827">{{cite journal |vauthors=Mylonas KS, Schizas D, Economopoulos KP |title=Adrenal ganglioneuroma: What you need to know |journal=World J Clin Cases |volume=5 |issue=10 |pages=373–377 |date=October 2017 |pmid=29085827 |pmc=5648998 |doi=10.12998/wjcc.v5.i10.373 |url=}}</ref><ref name="pmid24779851">{{cite journal |vauthors=Adas M, Koc B, Adas G, Ozulker F, Aydin T |title=Ganglioneuroma presenting as an adrenal incidentaloma: a case report |journal=J Med Case Rep |volume=8 |issue= |pages=131 |date=April 2014 |pmid=24779851 |pmc=4031973 |doi=10.1186/1752-1947-8-131 |url=}}</ref><ref name="pmid23661526">{{cite journal |vauthors=Li J, Yang CH, Li LM |title=Diagnosis and treatment of 29 cases of adrenal ganglioneuroma |journal=Eur Rev Med Pharmacol Sci |volume=17 |issue=8 |pages=1110–3 |date=April 2013 |pmid=23661526 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[catecholamines]]
* [[Catecholamines]]
* [[VIP]]
* [[VIP]]
* [[Cortisol]]
* [[Cortisol]]
Line 485: Line 517:
|
|
* N/L
* N/L
* ↑ [[plasma]] and [[urinary]] [[catecholamine]]
* ↑ [[Plasma]] and [[urinary]] [[catecholamine]]
* ↑ [[VIP]]
* ↑ [[VIP]]
* ↑ [[cortisol]] and [[testosterone]]
* ↑ [[Cortisol]] and [[testosterone]]
|
|
* Pathological examinations are gold standard.
* Mature type: mature [[Schwann cells]], [[ganglion cells]] and peri-[[neural]] [[cells]]
* Mature type: mature [[Schwann cells]], [[ganglion cells]] and peri-[[neural]] [[cells]]
* Maturing type: [[Schwann cells]], [[ganglion cells]] and peri-[[neural]] [[cells]] with varying [[maturation]]
* Maturing type: [[Schwann cells]], [[ganglion cells]] and peri-[[neural]] [[cells]] with varying [[maturation]]
|
|
* well-defined, Homogeneous ([[CT]])
* Pathological examinations are gold standard.
* Punctate or discrete [[calcification]] ([[CT]])
* Hypointense (T1-weighted)
* Varied signal (T2-weighted)
|
* [[Ultrasound]]
* [[Ultrasound]]
* [[Immunohistochemical staining]]
* [[Immunohistochemical staining]]
* <sup>18</sup>F-2-fluoro-deoxy-D-glucose-[[positron emission tomography]] ([[PET]])
* <sup>18</sup>F-2-fluoro-deoxy-D-glucose-[[positron emission tomography]] ([[PET]])
|
|
* Pathological examinations
* N/A
|
* Well-defined, Homogeneous
* Punctate or discrete [[calcification]]
|
* N/A
|
* Hypointense (T1-weighted)
* Varied signal (T2-weighted)
|
|
[[Stain|Stains]] positive for
[[Stain|Stains]] positive for:
* [[S-100|S100]]
* [[S-100|S100]]
* [[Synaptophysin]]
* [[Synaptophysin]]
Line 516: Line 553:
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Dianosis
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Gold
standard
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
Line 525: Line 560:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|+
|+
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lipoma]]/[[Myolipoma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid11533079">{{cite journal |vauthors=Lam KY, Lo CY |title=Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution |journal=J. Clin. Pathol. |volume=54 |issue=9 |pages=707–12 |date=September 2001 |pmid=11533079 |pmc=1731508 |doi= |url=}}</ref><ref name="pmid24328509">{{cite journal |vauthors=Gershuni VM, Bittner JG, Moley JF, Brunt LM |title=Adrenal myelolipoma: operative indications and outcomes |journal=J Laparoendosc Adv Surg Tech A |volume=24 |issue=1 |pages=8–12 |date=January 2014 |pmid=24328509 |pmc=3931430 |doi=10.1089/lap.2013.0411 |url=}}</ref><ref name="pmid26464739">{{cite journal |vauthors=Luo J, Chen L, Wen Q, Xu L, Chu S, Wang W, Alnemah MM, Fan S |title=Lipoadenoma of the adrenal gland: report of a rare entity and review of literature |journal=Int J Clin Exp Pathol |volume=8 |issue=8 |pages=9693–7 |date=2015 |pmid=26464739 |pmc=4583971 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lipoma]]/[[Myolipoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid11533079">{{cite journal |vauthors=Lam KY, Lo CY |title=Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution |journal=J. Clin. Pathol. |volume=54 |issue=9 |pages=707–12 |date=September 2001 |pmid=11533079 |pmc=1731508 |doi= |url=}}</ref><ref name="pmid24328509">{{cite journal |vauthors=Gershuni VM, Bittner JG, Moley JF, Brunt LM |title=Adrenal myelolipoma: operative indications and outcomes |journal=J Laparoendosc Adv Surg Tech A |volume=24 |issue=1 |pages=8–12 |date=January 2014 |pmid=24328509 |pmc=3931430 |doi=10.1089/lap.2013.0411 |url=}}</ref><ref name="pmid26464739">{{cite journal |vauthors=Luo J, Chen L, Wen Q, Xu L, Chu S, Wang W, Alnemah MM, Fan S |title=Lipoadenoma of the adrenal gland: report of a rare entity and review of literature |journal=Int J Clin Exp Pathol |volume=8 |issue=8 |pages=9693–7 |date=2015 |pmid=26464739 |pmc=4583971 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 544: Line 582:
* N/L
* N/L
|
|
* Pathological examinations are gold standard.
* Yellow [[adipose tissue]]
* Yellow [[adipose tissue]]
* [[Hemorrhagic]] foci
* [[Hemorrhagic]] foci
* Islands of [[Hematopoiesis lineages|hematopoietic cells]] ([[myolipoma]]) and mature [[fat cells]] ([[Lipoma]])
* Islands of [[Hematopoiesis lineages|hematopoietic cells]] ([[myolipoma]]) and mature [[fat cells]] ([[Lipoma]])
|
* [[Retro-peritoneal]] [[mass]]
* Well-defined heterogenous enhancement
* High signal ([[MRI]])
|
|
* [[Renal function tests|RFTs]]
* [[Renal function tests|RFTs]]
Line 557: Line 592:
* [[Ultrasound]]
* [[Ultrasound]]
|
|
* Pathological examinations
* Heterogeneous [[mass]]
|
* [[Retro-peritoneal]] [[mass]]
* Well-defined heterogenous enhancement
|
* N/A
|
* High signal
|
|
* [[Myolipoma]]: mature [[adipose tissue]] and [[haematopoietic]]  elements
* [[Myolipoma]]: mature [[adipose tissue]] and [[haematopoietic]]  elements
Line 565: Line 607:
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Product
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical manifestations
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |Dianosis
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnosis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Gold
standard
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Other features
|-
|-
Line 574: Line 614:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Blood & Urine
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histopathological
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Others
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Ultrasound
! style="background:#4479BA; color: #FFFFFF;" align="center" + |CT scan
! style="background:#4479BA; color: #FFFFFF;" align="center" + |FDG PET/CT
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MRI
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tuberculosis]]<ref name="pmid27006656">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Rendon A, Barrera-Sánchez M, Carlos-Reyna KE, Álvarez-Villalobos NA, González-Saldivar G, González-González JG |title=Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test |journal=Int J Endocrinol |volume=2016 |issue= |pages=9051865 |date=2016 |pmid=27006656 |pmc=4781954 |doi=10.1155/2016/9051865 |url=}}</ref><ref name="pmid15451821">{{cite journal |vauthors=Haddara WM, van Uum SH |title=TB and adrenal insufficiency |journal=CMAJ |volume=171 |issue=7 |pages=710; author reply 710–1 |date=September 2004 |pmid=15451821 |pmc=517840 |doi=10.1503/cmaj.1041046 |url=}}</ref><ref name="pmid26516430">{{cite journal |vauthors=Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW |title=Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status |journal=World J Radiol |volume=7 |issue=10 |pages=336–42 |date=October 2015 |pmid=26516430 |pmc=4620114 |doi=10.4329/wjr.v7.i10.336 |url=}}</ref><ref name="pmid28233510">{{cite journal |vauthors=Vinnard C, Blumberg EA |title=Endocrine and Metabolic Aspects of Tuberculosis |journal=Microbiol Spectr |volume=5 |issue=1 |pages= |date=January 2017 |pmid=28233510 |doi=10.1128/microbiolspec.TNMI7-0035-2016 |url=}}</ref><ref name="pmid23687365">{{cite journal |vauthors=Rajasekharan C, Ajithkumar S, Anto V, Parvathy R |title=Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine |journal=BMJ Case Rep |volume=2013 |issue= |pages= |date=May 2013 |pmid=23687365 |doi=10.1136/bcr-2012-008011 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tuberculosis]]<br><ref name="pmid27006656">{{cite journal |vauthors=Rodríguez-Gutiérrez R, Rendon A, Barrera-Sánchez M, Carlos-Reyna KE, Álvarez-Villalobos NA, González-Saldivar G, González-González JG |title=Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test |journal=Int J Endocrinol |volume=2016 |issue= |pages=9051865 |date=2016 |pmid=27006656 |pmc=4781954 |doi=10.1155/2016/9051865 |url=}}</ref><ref name="pmid15451821">{{cite journal |vauthors=Haddara WM, van Uum SH |title=TB and adrenal insufficiency |journal=CMAJ |volume=171 |issue=7 |pages=710; author reply 710–1 |date=September 2004 |pmid=15451821 |pmc=517840 |doi=10.1503/cmaj.1041046 |url=}}</ref><ref name="pmid26516430">{{cite journal |vauthors=Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW |title=Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status |journal=World J Radiol |volume=7 |issue=10 |pages=336–42 |date=October 2015 |pmid=26516430 |pmc=4620114 |doi=10.4329/wjr.v7.i10.336 |url=}}</ref><ref name="pmid28233510">{{cite journal |vauthors=Vinnard C, Blumberg EA |title=Endocrine and Metabolic Aspects of Tuberculosis |journal=Microbiol Spectr |volume=5 |issue=1 |pages= |date=January 2017 |pmid=28233510 |doi=10.1128/microbiolspec.TNMI7-0035-2016 |url=}}</ref><ref name="pmid23687365">{{cite journal |vauthors=Rajasekharan C, Ajithkumar S, Anto V, Parvathy R |title=Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine |journal=BMJ Case Rep |volume=2013 |issue= |pages= |date=May 2013 |pmid=23687365 |doi=10.1136/bcr-2012-008011 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 615: Line 658:
* Rim of [[granulomatous]] [[inflammatory cells]] ([[Langerhans giant cells]] and [[lymphocytes]])
* Rim of [[granulomatous]] [[inflammatory cells]] ([[Langerhans giant cells]] and [[lymphocytes]])
* Identifiable [[Acid fast|acid-fast stain]]-positive [[bacteria]] with [[Ziehl-Neelsen stain|Ziehl-Neelsen]] or [[Immunofluorescence|fluorescent stains]]
* Identifiable [[Acid fast|acid-fast stain]]-positive [[bacteria]] with [[Ziehl-Neelsen stain|Ziehl-Neelsen]] or [[Immunofluorescence|fluorescent stains]]
|
* Enlarged [[adrenal glands]]
* [[Calcification]]
* Hypodense areas ([[CT scan]])
* Rim enhancement ([[CT scan]])
* High [[FDG]] uptake by [[adrenal glands]] (18-[[FDG]] [[PET]]/[[CT]])
|
|
* [[Laparoscopic]] [[adrenalectomy]]
* [[Laparoscopic]] [[adrenalectomy]]
Line 630: Line 667:
* [[Metyrapone]] stimulation tests
* [[Metyrapone]] stimulation tests
|
|
* N/A
* Variable
|
* [[Calcification]]
* Hypodense areas
* Rim enhancement
|
* High [[FDG]] uptake by [[adrenal glands]]
|
* [[Calcification]]
* Variable signals
|
|
* Majority of the cases are secondary to:
* Majority of the cases are secondary to:
Line 638: Line 684:
* May present with [[shock]] with severe [[hypotension]] and [[hypoglycemia]] due to [[glucocorticoid]] insufficiency
* May present with [[shock]] with severe [[hypotension]] and [[hypoglycemia]] due to [[glucocorticoid]] insufficiency
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Histoplasmosis]]<ref name="pmid27995051">{{cite journal |vauthors=Rog CJ, Rosen DG, Gannon FH |title=Bilateral adrenal histoplasmosis in an immunocompetent man from Texas |journal=Med Mycol Case Rep |volume=14 |issue= |pages=4–7 |date=December 2016 |pmid=27995051 |pmc=5154969 |doi=10.1016/j.mmcr.2016.11.006 |url=}}</ref><ref name="pmid27047312">{{cite journal |vauthors=Wahab NA, Mohd R, Zainudin S, Kamaruddin NA |title=Adrenal involvement in histoplasmosis |journal=EXCLI J |volume=12 |issue= |pages=1–4 |date=2013 |pmid=27047312 |pmc=4817423 |doi= |url=}}</ref><ref name="pmid29888193">{{cite journal |vauthors=May D, Khaled D, Gills J |title=Unilateral adrenal histoplasmosis |journal=Urol Case Rep |volume=19 |issue= |pages=54–56 |date=July 2018 |pmid=29888193 |pmc=5991316 |doi=10.1016/j.eucr.2018.03.010 |url=}}</ref><ref name="pmid29643659">{{cite journal |vauthors=Gupta RK, Majumdar K, Srivastava S, Varakanahalli S, Saran RK |title=Endoscopic Ultrasound-guided Cytodiagnosis of Adrenal Histoplasmosis with Reversible CD4 T-Lymphocytopenia and Jejunal Lymphangiectasia |journal=J Cytol |volume=35 |issue=2 |pages=110–113 |date=2018 |pmid=29643659 |pmc=5885598 |doi=10.4103/JOC.JOC_234_15 |url=}}</ref><ref name="pmid25027093">{{cite journal |vauthors=Padma S, Sreehar S |title=18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient |journal=Indian J. Med. Res. |volume=139 |issue=5 |pages=786–7 |date=May 2014 |pmid=25027093 |pmc=4140048 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Histoplasmosis]]<br><ref name="pmid27995051">{{cite journal |vauthors=Rog CJ, Rosen DG, Gannon FH |title=Bilateral adrenal histoplasmosis in an immunocompetent man from Texas |journal=Med Mycol Case Rep |volume=14 |issue= |pages=4–7 |date=December 2016 |pmid=27995051 |pmc=5154969 |doi=10.1016/j.mmcr.2016.11.006 |url=}}</ref><ref name="pmid27047312">{{cite journal |vauthors=Wahab NA, Mohd R, Zainudin S, Kamaruddin NA |title=Adrenal involvement in histoplasmosis |journal=EXCLI J |volume=12 |issue= |pages=1–4 |date=2013 |pmid=27047312 |pmc=4817423 |doi= |url=}}</ref><ref name="pmid29888193">{{cite journal |vauthors=May D, Khaled D, Gills J |title=Unilateral adrenal histoplasmosis |journal=Urol Case Rep |volume=19 |issue= |pages=54–56 |date=July 2018 |pmid=29888193 |pmc=5991316 |doi=10.1016/j.eucr.2018.03.010 |url=}}</ref><ref name="pmid29643659">{{cite journal |vauthors=Gupta RK, Majumdar K, Srivastava S, Varakanahalli S, Saran RK |title=Endoscopic Ultrasound-guided Cytodiagnosis of Adrenal Histoplasmosis with Reversible CD4 T-Lymphocytopenia and Jejunal Lymphangiectasia |journal=J Cytol |volume=35 |issue=2 |pages=110–113 |date=2018 |pmid=29643659 |pmc=5885598 |doi=10.4103/JOC.JOC_234_15 |url=}}</ref><ref name="pmid25027093">{{cite journal |vauthors=Padma S, Sreehar S |title=18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient |journal=Indian J. Med. Res. |volume=139 |issue=5 |pages=786–7 |date=May 2014 |pmid=25027093 |pmc=4140048 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 676: Line 722:
* Focal ovoid bodies with a clear halo ([[PAS stain]])
* Focal ovoid bodies with a clear halo ([[PAS stain]])
|
|
* Enlarged [[adrenal glands]]
* [[Ultrasound]]-guided [[fine needle aspiration]] [[cytology]] ([[Ultrasound|USG]]-[[FNA|FNAC]]) is gold standard.
* [[Calcification]]
* Heterogeneous enhancement ([[CT]])
* Isointense [[adrenal]] [[mass]] ([[MRI]])
* Abnormal [[FDG]] uptake by [[adrenal glands]] (18-FDG [[PET]]/[[CT]])
|
* [[Laparoscopic]] [[adrenalectomy]]
* [[Laparoscopic]] [[adrenalectomy]]
* [[Endoscopic ultrasound]]
* [[Endoscopic ultrasound]]
* [[Abdominal ultrasound]]
* [[Ultrasound|Abdominal ultrasound]]
* [[Chest X-ray]]
* [[Chest X-ray]]
* [[ACTH]] stimulation test
* [[ACTH]] stimulation test
* [[Metyrapone]] stimulation tests
* [[Metyrapone]] stimulation tests
|
|
* [[Ultrasound]]-guided [[fine needle aspiration]] [[cytology]] ([[Ultrasound|USG]]-[[FNA|FNAC]])
* Enlarged [[adrenal glands]]
* [[Calcification]]
|
* Enlarged [[adrenal glands]]
* [[Calcification]]
* Heterogeneous enhancement
|
* Abnormal [[FDG]] uptake by [[adrenal glands]]
|
* Enlarged [[adrenal glands]]
* [[Calcification]]
* Isointense [[adrenal]] [[mass]] ([[MRI]])
|
|
* [[Patient]] may exhibit no [[clinical manifestations]] of [[adrenal]] involvement
* [[Patient]] may exhibit no [[clinical manifestations]] of [[adrenal]] involvement
Line 697: Line 749:
* May present with [[shock]] with severe [[hypotension]] and [[hypoglycemia]] due to [[glucocorticoid]] insufficiency
* May present with [[shock]] with severe [[hypotension]] and [[hypoglycemia]] due to [[glucocorticoid]] insufficiency
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cysts]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28246490">{{cite journal |vauthors=Carsote M, Ghemigian A, Terzea D, Gheorghisan-Galateanu AA, Valea A |title=Cystic adrenal lesions: focus on pediatric population (a review) |journal=Clujul Med |volume=90 |issue=1 |pages=5–12 |date=2017 |pmid=28246490 |doi=10.15386/cjmed-677 |url=}}</ref><ref name="pmid26807295">{{cite journal |vauthors=Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, Kasperlik-Załuska AA |title=Standards of ultrasound imaging of the adrenal glands |journal=J Ultrason |volume=15 |issue=63 |pages=377–87 |date=December 2015 |pmid=26807295 |pmc=4710689 |doi=10.15557/JoU.2015.0035 |url=}}</ref><ref name="pmid29881567">{{cite journal |vauthors=Olaoye IO, Adesina MD, Afolayan EA |title=A giant adrenal cyst with an uncertain preoperative diagnosis causing a dilemma in management |journal=Clin Case Rep |volume=6 |issue=6 |pages=1074–1076 |date=June 2018 |pmid=29881567 |pmc=5986023 |doi=10.1002/ccr3.1519 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cysts]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28246490">{{cite journal |vauthors=Carsote M, Ghemigian A, Terzea D, Gheorghisan-Galateanu AA, Valea A |title=Cystic adrenal lesions: focus on pediatric population (a review) |journal=Clujul Med |volume=90 |issue=1 |pages=5–12 |date=2017 |pmid=28246490 |doi=10.15386/cjmed-677 |url=}}</ref><ref name="pmid26807295">{{cite journal |vauthors=Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, Kasperlik-Załuska AA |title=Standards of ultrasound imaging of the adrenal glands |journal=J Ultrason |volume=15 |issue=63 |pages=377–87 |date=December 2015 |pmid=26807295 |pmc=4710689 |doi=10.15557/JoU.2015.0035 |url=}}</ref><ref name="pmid29881567">{{cite journal |vauthors=Olaoye IO, Adesina MD, Afolayan EA |title=A giant adrenal cyst with an uncertain preoperative diagnosis causing a dilemma in management |journal=Clin Case Rep |volume=6 |issue=6 |pages=1074–1076 |date=June 2018 |pmid=29881567 |pmc=5986023 |doi=10.1002/ccr3.1519 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
|
|
* [[Abdominal]] [[pain]]
* [[Abdominal]] [[pain]]
* [[abdominal]] [[mass]]
* [[Abdominal Aortic Aneurysm|Abdominal]] [[mass]]
* [[Abdominal]] fullness
* [[Abdominal]] fullness
* [[Hematuria]]
* [[Hematuria]]
Line 722: Line 774:
* [[Pseudocyst]]: lined by [[fibrous tissue]]
* [[Pseudocyst]]: lined by [[fibrous tissue]]
* [[Hydatid cyst]]: 3 layers (germinal layer, laminated [[membrane]] and dense [[fibrovascular tissue]])
* [[Hydatid cyst]]: 3 layers (germinal layer, laminated [[membrane]] and dense [[fibrovascular tissue]])
|
* Complete [[endocrine]] panel
* [<sup>18</sup>F][[FDG]] [[PET]]/[[CT]] (if [[malignancy]] is suspected)
* [[Biopsy]] (if [[malignancy]] is suspected)
* [[ACTH]] stimulation test
|
* Gold standard
* Circumscribed anechoic or hypoechoic mass
|
|
* Homogeneous [[mass]]
* Homogeneous [[mass]]
* No enhancement
* No enhancement
* [[Calcification]]
* [[Calcification]]
* Low density ([[CT]])
* Low density
* High signal ([[MRI]])
* Circumscribed anechoic or hypoechoic mass ([[Ultrasound]])
|
|
* Complete [[endocrine]] panel
* N/A
* [<sup>18</sup>F][[FDG]] [[PET]]/[[CT]] (if [[malignancy]] is suspected)
* [[Biopsy]] (if [[malignancy]] is suspected)
* [[ACTH]] stimulation test
|
|
* [[Ultrasonography]]
* High signal
|
|
* 3 major subtypes
* 3 major subtypes
Line 742: Line 797:
** [[Cystic]] part of an otherwise solid [[tumor]]
** [[Cystic]] part of an otherwise solid [[tumor]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haematoma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid14747454">{{cite journal |vauthors=Hamilton D, Harris MD, Foweraker J, Gresham GA |title=Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection |journal=J. Clin. Pathol. |volume=57 |issue=2 |pages=208–9 |date=February 2004 |pmid=14747454 |pmc=1770213 |doi= |url=}}</ref><ref name="pmid28828107">{{cite journal |vauthors=Di Serafino M, Severino R, Coppola V, Gioioso M, Rocca R, Lisanti F, Scarano E |title=Nontraumatic adrenal hemorrhage: the adrenal stress |journal=Radiol Case Rep |volume=12 |issue=3 |pages=483–487 |date=September 2017 |pmid=28828107 |pmc=5551907 |doi=10.1016/j.radcr.2017.03.020 |url=}}</ref><ref name="pmid29770310">{{cite journal |vauthors=Ierardi AM, Petrillo M, Patella F, Biondetti P, Fumarola EM, Angileri SA, Pesapane F, Pinto A, Dionigi G, Carrafiello G |title=Interventional radiology of the adrenal glands: current status |journal=Gland Surg |volume=7 |issue=2 |pages=147–165 |date=April 2018 |pmid=29770310 |pmc=5938278 |doi=10.21037/gs.2018.01.04 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hematoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid14747454">{{cite journal |vauthors=Hamilton D, Harris MD, Foweraker J, Gresham GA |title=Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection |journal=J. Clin. Pathol. |volume=57 |issue=2 |pages=208–9 |date=February 2004 |pmid=14747454 |pmc=1770213 |doi= |url=}}</ref><ref name="pmid28828107">{{cite journal |vauthors=Di Serafino M, Severino R, Coppola V, Gioioso M, Rocca R, Lisanti F, Scarano E |title=Nontraumatic adrenal hemorrhage: the adrenal stress |journal=Radiol Case Rep |volume=12 |issue=3 |pages=483–487 |date=September 2017 |pmid=28828107 |pmc=5551907 |doi=10.1016/j.radcr.2017.03.020 |url=}}</ref><ref name="pmid29770310">{{cite journal |vauthors=Ierardi AM, Petrillo M, Patella F, Biondetti P, Fumarola EM, Angileri SA, Pesapane F, Pinto A, Dionigi G, Carrafiello G |title=Interventional radiology of the adrenal glands: current status |journal=Gland Surg |volume=7 |issue=2 |pages=147–165 |date=April 2018 |pmid=29770310 |pmc=5938278 |doi=10.21037/gs.2018.01.04 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 766: Line 821:
* [[Pseudocyst]]: lined by [[fibrous tissue]]
* [[Pseudocyst]]: lined by [[fibrous tissue]]
* Findings related to underlying cause
* Findings related to underlying cause
|
* High density (acute [[hemorrhage]] on [[CT]])
* Isointense and low signal (Early [[hemorrhage]] on [[MRI]])
* Hypointense (Late [[hemorrhage]] on [[MRI]])
|
|
* [[Adrenal]] [[ultrasound]]
* [[Adrenal]] [[ultrasound]]
* [[ACTH]] stimulation test
* [[ACTH]] stimulation test
* Tests related to underlying cause
* Tests related to underlying cause
|
* Variable
|
* High density (acute [[hemorrhage]])
|
|
* N/A
* N/A
|
* Isointense and low signal (Early [[hemorrhage]])
* Hypointense (Late [[hemorrhage]])
|
|
* Majority of the cases in [[neonantal]] peiod
* Majority of the cases in [[neonantal]] peiod
* Majority of the cases caused by [[trauma]]
* Majority of the cases caused by [[trauma]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemangioma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid22701011">{{cite journal |vauthors=Alhajri K, Alhasan I, Alzerwi N, Abudaff N |title=Adrenal haemangioma |journal=BMJ Case Rep |volume=2011 |issue= |pages= |date=April 2011 |pmid=22701011 |pmc=3079485 |doi=10.1136/bcr.12.2010.3604 |url=}}</ref><ref name="pmid29560018">{{cite journal |vauthors=Iwamoto G, Shimokihara K, Kawahara T, Takamoto D, Yao M, Teranishi JI, Otani M, Uemura H |title=Adrenal Hemangioma: A Case of Retroperitoneal Tumor |journal=Case Rep Med |volume=2018 |issue= |pages=8796327 |date=2018 |pmid=29560018 |pmc=5836307 |doi=10.1155/2018/8796327 |url=}}</ref><ref name="pmid26600897">{{cite journal |vauthors=Tarchouli M, Boudhas A, Ratbi MB, Essarghini M, Njoumi N, Sair K, Zentar A |title=Giant adrenal hemangioma: Unusual cause of huge abdominal mass |journal=Can Urol Assoc J |volume=9 |issue=11-12 |pages=E834–6 |date=2015 |pmid=26600897 |pmc=4639440 |doi=10.5489/cuaj.2967 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemangioma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid22701011">{{cite journal |vauthors=Alhajri K, Alhasan I, Alzerwi N, Abudaff N |title=Adrenal haemangioma |journal=BMJ Case Rep |volume=2011 |issue= |pages= |date=April 2011 |pmid=22701011 |pmc=3079485 |doi=10.1136/bcr.12.2010.3604 |url=}}</ref><ref name="pmid29560018">{{cite journal |vauthors=Iwamoto G, Shimokihara K, Kawahara T, Takamoto D, Yao M, Teranishi JI, Otani M, Uemura H |title=Adrenal Hemangioma: A Case of Retroperitoneal Tumor |journal=Case Rep Med |volume=2018 |issue= |pages=8796327 |date=2018 |pmid=29560018 |pmc=5836307 |doi=10.1155/2018/8796327 |url=}}</ref><ref name="pmid26600897">{{cite journal |vauthors=Tarchouli M, Boudhas A, Ratbi MB, Essarghini M, Njoumi N, Sair K, Zentar A |title=Giant adrenal hemangioma: Unusual cause of huge abdominal mass |journal=Can Urol Assoc J |volume=9 |issue=11-12 |pages=E834–6 |date=2015 |pmid=26600897 |pmc=4639440 |doi=10.5489/cuaj.2967 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* [[Cortisol]] (rare)
* [[Cortisol]] (rare)
Line 800: Line 858:
* ↑ [[Serum]] and [[urinary]] [[Adrenal gland|adrenal hormones]] and [[metabolites]] (very rare)
* ↑ [[Serum]] and [[urinary]] [[Adrenal gland|adrenal hormones]] and [[metabolites]] (very rare)
|
|
* [[Histopathology]] is gold standard
* Most often [[cavernous]]
* Most often [[cavernous]]
* Peripheral dilated [[vascular]] spaces
* Peripheral dilated [[vascular]] spaces
Line 807: Line 866:
* [[Calcification]]
* [[Calcification]]
* [[Hemorrhage]]
* [[Hemorrhage]]
*
*
|
* [[Calcification]]
* [[Phleboliths]]
* Irregular peripheral enhancement ([[CT]])
* Hyperintensity (T2) hypointensity (T1)([[MRI]])
* Peripheral spotty and centripetal enhancement ([[MRI]])
|
|
* Complete [[endocrine]] panel
* Complete [[endocrine]] panel
Line 824: Line 873:
* Post-[[resection]] [[biopsy]] (if [[malignancy]] is suspected)
* Post-[[resection]] [[biopsy]] (if [[malignancy]] is suspected)
|
|
* [[Histopathology]]
* [[Calcification]]
* [[Phleboliths]]
|
* [[Calcification]]
* [[Phleboliths]]
* Irregular peripheral enhancement
|
* N/A
|
* Hyperintensity (T2) hypointensity (T1)
* Peripheral spotty and centripetal enhancement
|
|
* Majority of the cases diagnosed incidentally
* Majority of the cases diagnosed incidentally
* Majority of the [[lesions]] are non-functional with [[female]] pre-dominance
* Majority of the [[lesions]] are non-functional with [[female]] pre-dominance
*
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphoma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28794358">{{cite journal |vauthors=Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F |title=The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency |journal=Intern. Med. |volume=56 |issue=17 |pages=2261–2269 |date=September 2017 |pmid=28794358 |pmc=5635296 |doi=10.2169/internalmedicine.8216-16 |url=}}</ref><ref name="pmid27795295">{{cite journal |vauthors=Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM |title=Adrenal lymphoma: presentation, management and prognosis |journal=QJM |volume=110 |issue=2 |pages=103–109 |date=February 2017 |pmid=27795295 |doi=10.1093/qjmed/hcw174 |url=}}</ref><ref name="pmid29344029">{{cite journal |vauthors=Karimi F |title=Primary Adrenal Lymphoma Presenting with Adrenal Failure: A Case Report and Review of the Literature |journal=Int J Endocrinol Metab |volume=15 |issue=4 |pages=e12014 |date=October 2017 |pmid=29344029 |pmc=5750783 |doi=10.5812/ijem.12014 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid28794358">{{cite journal |vauthors=Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F |title=The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency |journal=Intern. Med. |volume=56 |issue=17 |pages=2261–2269 |date=September 2017 |pmid=28794358 |pmc=5635296 |doi=10.2169/internalmedicine.8216-16 |url=}}</ref><ref name="pmid27795295">{{cite journal |vauthors=Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM |title=Adrenal lymphoma: presentation, management and prognosis |journal=QJM |volume=110 |issue=2 |pages=103–109 |date=February 2017 |pmid=27795295 |doi=10.1093/qjmed/hcw174 |url=}}</ref><ref name="pmid29344029">{{cite journal |vauthors=Karimi F |title=Primary Adrenal Lymphoma Presenting with Adrenal Failure: A Case Report and Review of the Literature |journal=Int J Endocrinol Metab |volume=15 |issue=4 |pages=e12014 |date=October 2017 |pmid=29344029 |pmc=5750783 |doi=10.5812/ijem.12014 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 857: Line 914:
* ↓ [[Aldosterone]]
* ↓ [[Aldosterone]]
|
|
* [[Histopathology]] is gold standard
* Diffuse growth pattern with large [[cells]] ( 5× normal [[lymphocytes]]) resembling [[immunoblasts]]  
* Diffuse growth pattern with large [[cells]] ( 5× normal [[lymphocytes]]) resembling [[immunoblasts]]  
* Extensive [[necrosis]]
* Extensive [[necrosis]]
* May resemble [[anaplastic]] large [[cell]] [[lymphoma]] or [[metastatic]] [[carcinoma]]
* May resemble [[anaplastic]] large [[cell]] [[lymphoma]] or [[metastatic]] [[carcinoma]]
* Abundant [[T-cells]]
* Abundant [[T-cells]]
|
* Heterogeneous [[mass]]
* [[Hemorrhages]]
* [[Necrosis]]
* Enlarged [[retroperitoneal]] [[lymph nodes]] ([[MRI]])
* Low intensity (T1-[[MRI]])
* High intensity (T2-[[MRI]]))
|
|
* Complete [[endocrine]] panel
* Complete [[endocrine]] panel
Line 875: Line 926:
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
|
|
* [[Histopathology]]
* Heterogeneous [[mass]]  
* [[Hemorrhages]]
|
* Heterogeneous [[mass]]
* [[Hemorrhages]]
* [[Necrosis]]
|
* N/A
|
|
* May stain positive for  
* Enlarged [[retroperitoneal]] [[lymph nodes]]
* Low intensity (T1)
* High intensity (T2)
|
* May stain positive for:
** [[CD3]], [[CD19]], [[CD20]], [[CD22]]
** [[CD3]], [[CD19]], [[CD20]], [[CD22]]
** [[BCL6]] / [[CD10]]
** [[BCL6]] / [[CD10]]
Line 887: Line 949:
** [[Pax genes|Pax 5]]
** [[Pax genes|Pax 5]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystic Lymphangioma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid27011561">{{cite journal |vauthors=Michalopoulos N, Laskou S, Karayannopoulou G, Pavlidis L, Kanellos I |title=Adrenal Gland Lymphangiomas |journal=Indian J Surg |volume=77 |issue=Suppl 3 |pages=1334–42 |date=December 2015 |pmid=27011561 |pmc=4775622 |doi=10.1007/s12262-015-1206-y |url=}}</ref><ref name="pmid25197378">{{cite journal |vauthors=Zhao M, Gu Q, Li C, Yu J, Qi H |title=Cystic lymphangioma of adrenal gland: a clinicopathological study of 3 cases and review of literature |journal=Int J Clin Exp Pathol |volume=7 |issue=8 |pages=5051–6 |date=2014 |pmid=25197378 |pmc=4152068 |doi= |url=}}</ref><ref name="pmid25889625">{{cite journal |vauthors=Joliat GR, Melloul E, Djafarrian R, Schmidt S, Fontanella S, Yan P, Demartines N, Halkic N |title=Cystic lymphangioma of the adrenal gland: report of a case and review of the literature |journal=World J Surg Oncol |volume=13 |issue= |pages=58 |date=February 2015 |pmid=25889625 |pmc=4335415 |doi=10.1186/s12957-015-0490-0 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cystic Lymphangioma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid27011561">{{cite journal |vauthors=Michalopoulos N, Laskou S, Karayannopoulou G, Pavlidis L, Kanellos I |title=Adrenal Gland Lymphangiomas |journal=Indian J Surg |volume=77 |issue=Suppl 3 |pages=1334–42 |date=December 2015 |pmid=27011561 |pmc=4775622 |doi=10.1007/s12262-015-1206-y |url=}}</ref><ref name="pmid25197378">{{cite journal |vauthors=Zhao M, Gu Q, Li C, Yu J, Qi H |title=Cystic lymphangioma of adrenal gland: a clinicopathological study of 3 cases and review of literature |journal=Int J Clin Exp Pathol |volume=7 |issue=8 |pages=5051–6 |date=2014 |pmid=25197378 |pmc=4152068 |doi= |url=}}</ref><ref name="pmid25889625">{{cite journal |vauthors=Joliat GR, Melloul E, Djafarrian R, Schmidt S, Fontanella S, Yan P, Demartines N, Halkic N |title=Cystic lymphangioma of the adrenal gland: report of a case and review of the literature |journal=World J Surg Oncol |volume=13 |issue= |pages=58 |date=February 2015 |pmid=25889625 |pmc=4335415 |doi=10.1186/s12957-015-0490-0 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 903: Line 965:
* N/L
* N/L
|
|
* [[Histopathology]] is gold standard
* Cystic channels and spaces
* Cystic channels and spaces
* Flat [[endothelial cells]]
* Flat [[endothelial cells]]
* Mature [[lymphoid]] aggregates
* Mature [[lymphoid]] aggregates
|
* Complete [[endocrine]] panel
* [[Ultrasound]]
* [[FDG]]-[[PET]] scan
* [[Aspiration]] & [[biopsy]]
|
* Well-demarcated
* [[Calcification]]
|
|
* Well-demarcated
* Well-demarcated
* Low-density
* Low-density
* [[Calcification]]
* [[Calcification]]
* T1 hypointense & T2 hyperintense ([[MRI]])
|
|
* Complete [[endocrine]] panel
* N/A
* [[Ultrasound]]
* [[FDG]]-[[PET]] scan
* [[Aspiration]] & [[biopsy]]
|
|
* [[Histopathology]]
* T1 hypointense & T2 hyperintense
|
|
* Associated with [[Gorlin-Goltz syndrome]]
* Associated with [[Gorlin-Goltz syndrome]]
* Stains positive for [[CD31]], [[CD34]], and D2-40 and negative for [[cytokeratin]]
* Stains positive for [[CD31]], [[CD34]], and D2-40 and negative for [[cytokeratin]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Teratoma]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid29067922">{{cite journal |vauthors=Ramakant P, Rana C, Singh KR, Mishra A |title=Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management |journal=J Postgrad Med |volume=64 |issue=2 |pages=112–114 |date=2018 |pmid=29067922 |pmc=5954807 |doi=10.4103/jpgm.JPGM_588_16 |url=}}</ref><ref name="pmid26722254">{{cite journal |vauthors=Li S, Li H, Ji Z, Yan W, Zhang Y |title=Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults |journal=Oncol Lett |volume=10 |issue=5 |pages=2865–2870 |date=November 2015 |pmid=26722254 |pmc=4665718 |doi=10.3892/ol.2015.3701 |url=}}</ref><ref name="pmid30214733">{{cite journal |vauthors=Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, Ni L, Yang S, Chen Y, Lai Y |title=Primary adrenal teratoma: A case series and review of the literature |journal=Mol Clin Oncol |volume=9 |issue=4 |pages=437–442 |date=October 2018 |pmid=30214733 |pmc=6125700 |doi=10.3892/mco.2018.1687 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Teratoma]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid29067922">{{cite journal |vauthors=Ramakant P, Rana C, Singh KR, Mishra A |title=Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management |journal=J Postgrad Med |volume=64 |issue=2 |pages=112–114 |date=2018 |pmid=29067922 |pmc=5954807 |doi=10.4103/jpgm.JPGM_588_16 |url=}}</ref><ref name="pmid26722254">{{cite journal |vauthors=Li S, Li H, Ji Z, Yan W, Zhang Y |title=Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults |journal=Oncol Lett |volume=10 |issue=5 |pages=2865–2870 |date=November 2015 |pmid=26722254 |pmc=4665718 |doi=10.3892/ol.2015.3701 |url=}}</ref><ref name="pmid30214733">{{cite journal |vauthors=Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, Ni L, Yang S, Chen Y, Lai Y |title=Primary adrenal teratoma: A case series and review of the literature |journal=Mol Clin Oncol |volume=9 |issue=4 |pages=437–442 |date=October 2018 |pmid=30214733 |pmc=6125700 |doi=10.3892/mco.2018.1687 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* N/A
* N/A
Line 944: Line 1,011:
|
|
* [[Fibrous tissue]], [[adipose tissue]] and [[muscle fibers]]
* [[Fibrous tissue]], [[adipose tissue]] and [[muscle fibers]]
* [[stratified squamous epithelium]], [[hair]] shafts, [[fat cells]], [[GI]] and [[respiratory]] [[epithelium]]
* [[Stratified squamous epithelium]], [[hair]] shafts, [[fat cells]], [[GI]] and [[respiratory]] [[epithelium]]
* [[Necrosis]]
* [[Necrosis]]
* [[Calcification]]
* [[Calcification]]
|
* Complete [[endocrine]] panel
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
* Post-resection [[biopsy]] (if [[malignancy]] is suspected)
|
|
* Heterogeneous  
* Heterogeneous  
* Mixed echo ([[Ultrasonogram|U/S]])
* Mixed echo ([[Ultrasonogram|U/S]])
* Mixed density elements ([[CT scan]])
|
* Heterogeneous
* Mixed density elements  
* Egg-shell [[calcification]]
* Egg-shell [[calcification]]
* Mild enhancement
* Mild enhancement
* Mixed signals ([[MRI]])
|
|
* Complete [[endocrine]] panel
* N/A
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
* Post-resection [[biopsy]] (if [[malignancy]] is suspected)
|
|
* N/A
* Mild enhancement
* Mixed signals ([[MRI]])
|
|
* Derived from [[germ layers]]
* Derived from [[germ layers]]
* Majority are [[benign]], but about one forth of [[adrenal]] [[teratoma]] are [[malignant]] [[lesions]]
* Majority are [[benign]], but about one forth of [[adrenal]] [[teratoma]] are [[malignant]] [[lesions]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Metastases]]<ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid15541184">{{cite journal |vauthors=Karanikiotis C, Tentes AA, Markakidis S, Vafiadis K |title=Large bilateral adrenal metastases in non-small cell lung cancer |journal=World J Surg Oncol |volume=2 |issue= |pages=37 |date=November 2004 |pmid=15541184 |pmc=535544 |doi=10.1186/1477-7819-2-37 |url=}}</ref><ref name="pmid15405683">{{cite journal |vauthors=ABRAMS HL, SPIRO R, GOLDSTEIN N |title=Metastases in carcinoma; analysis of 1000 autopsied cases |journal=Cancer |volume=3 |issue=1 |pages=74–85 |date=January 1950 |pmid=15405683 |doi= |url=}}</ref><ref name="pmid15554272">{{cite journal |vauthors=Gerber E, Dinlenc C, Wagner JR |title=Laparoscopic adrenalectomy for isolated adrenal metastasis |journal=JSLS |volume=8 |issue=4 |pages=314–9 |date=2004 |pmid=15554272 |pmc=3016821 |doi= |url=}}</ref><ref name="pmid9781426">{{cite journal |vauthors=Vaughan ED |title=Diagnosis and management of surgical adrenal disorders |journal=Int. J. Urol. |volume=5 |issue=5 |pages=401–17 |date=September 1998 |pmid=9781426 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Metastases]]<br><ref name="pmid30306064">{{cite journal |vauthors=Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T |title=CT and MRI of adrenal gland pathologies |journal=Quant Imaging Med Surg |volume=8 |issue=8 |pages=853–875 |date=September 2018 |pmid=30306064 |pmc=6177362 |doi=10.21037/qims.2018.09.13 |url=}}</ref><ref name="pmid15541184">{{cite journal |vauthors=Karanikiotis C, Tentes AA, Markakidis S, Vafiadis K |title=Large bilateral adrenal metastases in non-small cell lung cancer |journal=World J Surg Oncol |volume=2 |issue= |pages=37 |date=November 2004 |pmid=15541184 |pmc=535544 |doi=10.1186/1477-7819-2-37 |url=}}</ref><ref name="pmid15405683">{{cite journal |vauthors=ABRAMS HL, SPIRO R, GOLDSTEIN N |title=Metastases in carcinoma; analysis of 1000 autopsied cases |journal=Cancer |volume=3 |issue=1 |pages=74–85 |date=January 1950 |pmid=15405683 |doi= |url=}}</ref><ref name="pmid15554272">{{cite journal |vauthors=Gerber E, Dinlenc C, Wagner JR |title=Laparoscopic adrenalectomy for isolated adrenal metastasis |journal=JSLS |volume=8 |issue=4 |pages=314–9 |date=2004 |pmid=15554272 |pmc=3016821 |doi= |url=}}</ref><ref name="pmid9781426">{{cite journal |vauthors=Vaughan ED |title=Diagnosis and management of surgical adrenal disorders |journal=Int. J. Urol. |volume=5 |issue=5 |pages=401–17 |date=September 1998 |pmid=9781426 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Related to the primary [[tumor]]
* Related to the primary [[tumor]]
Line 1,012: Line 1,083:
* [[Morphology]] similar to the primary [[tumor]]
* [[Morphology]] similar to the primary [[tumor]]
* Compression and [[atrophy]] of adjacent [[adrenal]] [[tissue]]
* Compression and [[atrophy]] of adjacent [[adrenal]] [[tissue]]
|
* [[Calcification]]
* [[Hemorrhage]]
* Irregular peripheral enhancement
* Low signal on T1-weighed [[MRI]] and high signal on T2-weighed [[MRI]]
OR
* Isointense on T1- and T2-weighed [[MRI]]
|
|
* [[Blood]] and [[urine]] lab testing
* [[Blood]] and [[urine]] lab testing
Line 1,027: Line 1,091:
* [[MRCP]] & [[ERCP]]
* [[MRCP]] & [[ERCP]]
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
* <sup>18</sup>F-fluorodeoxyglucose ([[FDG]]) [[positron emission tomography]] [[PET]]/[[CT]]
|
* [[Calcification]]
* [[Hemorrhage]]
|
* [[Calcification]]
* [[Hemorrhage]]
* Irregular peripheral enhancement
|
|
* N/A
* N/A
|
* Low signal on T1-weighed [[MRI]] and high signal on T2-weighed [[MRI]]
OR
* Isointense on T1- and T2-weighed [[MRI]]
|
|
* [[Metastases]] more common than primary [[adrenal tumors]]
* [[Metastases]] more common than primary [[adrenal tumors]]

Latest revision as of 19:30, 22 February 2019

Abbreviations

ACTH: Adrenocorticotropic hormone, ARR: Aldosterone-renin ratio, CAM: Cellular adhesion molecules, ERCP: Endoscopic retrograde cholangiopancreatography, ESR: Erythrocyte sedimentation rate, CT: Computerized tomography, Fluorescence in situ hybridization, FDG: Fluorodeoxyglucose, FSH: Follicle stimulating hormone, GI: Gastrointestinal, H&E stain: Hematoxylin and eosin stain, LCA: Leukocyte common antigen, LDH: Lactate dehydrogenase, LH: Luteinizing hormone, MEN: Multiple endocrine neoplasia, MRCP: Magnetic resonance cholangiopancreatography, MRI: Magnetic resonance imaging, N/A: Not applicable/Not available, N/L: Normal, PAS stain: Periodic acid–Schiff stain, PET: Position emission tomography, PGP: Protein gene product 9.5, TB: Tuberculosis, U/S: Ultrasound, ZF: Zona fasciculata, ZG: Zona granulosa, ZR: Zona reticularis.

Adrenal Cortex Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Adrenal Adenoma Aldosterone
[1][2][3][4]
  • Iso and low FDG uptake compared with liver
  • Hyperintense on in-phase and hypointense on oppose-phase
Cortisol
[1][5][6][7]
  • Iso and low FDG uptake compared with liver
  • Hyperintense on in-phase and hypointense on oppose-phase
Androgens
[4][8][9][10]
  • Well-defined
  • Solid mass
  • N/A
  • Hyperintense on in-phase and hypointense on oppose-phase
Non-functional
[1][11][12][13]
  • Solid, well defined mass
  • High lipid content and adjacent compression
  • N/A
  • Hyperintense on in-phase and hypointense on oppose-phase
Adrenal Carcinoma
[12][14][15][16][17]
  • N/A
  • Heterogeneous enhancement
  • Heterogeneous mass with intense FDG uptake greater than liver
  • Heterogenous hyper-intensity (T2-weighted) and hypo-intensity on (T1-weighted)
Adrenal Hyperplasia
[2][5][4][8][9][15][18][19]
  • N/A
  • Unilateral or bilateral adrenal enlargement or thickening
  • Signaling is same as that of normal adrenal gland
Medulla Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Pheochromocytoma
[20][21][22][23][24]
  • N/A
Neuroblastoma
[15][25][26][27]
  • Large mass
  • May cross midline
  • N/A
Stains positive for:
Ganglioneuroma
[15][28][29][30]
  • N/A
  • N/A
  • Hypointense (T1-weighted)
  • Varied signal (T2-weighted)

Stains positive for:

Stroma Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Lipoma/Myolipoma
[15][31][32][33]
  • N/A
  • N/L
  • N/A
  • High signal
Others Product Clinical manifestations Diagnosis Other features
Symptoms Signs Blood & Urine Histopathological Others Ultrasound CT scan FDG PET/CT MRI
Tuberculosis
[34][35][36][37][38]
  • N/A
  • Variable
Histoplasmosis
[39][40][41][42][43]
  • N/A
Cysts
[15][44][45][46]
  • N/A
  • Gold standard
  • Circumscribed anechoic or hypoechoic mass
  • N/A
  • High signal
Hematoma
[15][47][48][49]
  • N/A
  • Variable
  • N/A
  • Majority of the cases in neonantal peiod
  • Majority of the cases caused by trauma
Hemangioma
[15][50][51][52]
  • N/A
  • Hyperintensity (T2) hypointensity (T1)
  • Peripheral spotty and centripetal enhancement
  • Majority of the cases diagnosed incidentally
  • Majority of the lesions are non-functional with female pre-dominance
Lymphoma
[15][53][54][55]
  • N/A
  • N/A
Cystic Lymphangioma
[15][56][57][58]
  • N/A
  • N/L
  • N/A
  • T1 hypointense & T2 hyperintense
Teratoma
[15][59][60][61]
  • N/A
  • N/L
  • Heterogeneous
  • Mixed echo (U/S)
  • Heterogeneous
  • Mixed density elements
  • Egg-shell calcification
  • Mild enhancement
  • N/A
  • Mild enhancement
  • Mixed signals (MRI)
Metastases
[15][62][63][64][65]
  • Related to the primary tumor
  • N/A
  • Low signal on T1-weighed MRI and high signal on T2-weighed MRI

OR

  • Isointense on T1- and T2-weighed MRI

References

  1. 1.0 1.1 1.2 Park JJ, Park BK, Kim CK (June 2016). "Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses". Br J Radiol. 89 (1062): 20151018. doi:10.1259/bjr.20151018. PMC 5258164. PMID 26867466.
  2. 2.0 2.1 Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P (August 2015). "Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas". Mol. Cell. Endocrinol. 411: 146–54. doi:10.1016/j.mce.2015.04.022. PMC 4474471. PMID 25958045.
  3. Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (May 2010). "Laboratory investigation of primary aldosteronism". Clin Biochem Rev. 31 (2): 39–56. PMC 2874431. PMID 20498828.
  4. 4.0 4.1 4.2 Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C (2013). "Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging". J Clin Imaging Sci. 3: 61. doi:10.4103/2156-7514.124088. PMC 3935261. PMID 24605256.
  5. 5.0 5.1 Stratakis CA (2008). "Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)". Endocr Dev. 13: 117–32. doi:10.1159/000134829. PMC 3132884. PMID 18493137.
  6. Zilbermint M, Stratakis CA (June 2015). "Protein kinase A defects and cortisol-producing adrenal tumors". Curr Opin Endocrinol Diabetes Obes. 22 (3): 157–62. doi:10.1097/MED.0000000000000149. PMC 4560837. PMID 25871963.
  7. Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J (April 2018). "ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures". BMC Endocr Disord. 18 (1): 22. doi:10.1186/s12902-018-0250-6. PMC 5913873. PMID 29685132.
  8. 8.0 8.1 Arnold DT, Reed JB, Burt K (January 2003). "Evaluation and management of the incidental adrenal mass". Proc (Bayl Univ Med Cent). 16 (1): 7–12. PMC 1200803. PMID 16278716.
  9. 9.0 9.1 Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J (2013). "Pure androgen-secreting adrenal adenoma associated with resistant hypertension". Case Rep Endocrinol. 2013: 356086. doi:10.1155/2013/356086. PMC 3681270. PMID 23819074.
  10. Zhou WB, Chen N, Li CJ (January 2019). "A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman". BMC Endocr Disord. 19 (1): 14. doi:10.1186/s12902-019-0342-y. PMC 6343319. PMID 30674304.
  11. Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A (October 2016). ""Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study". Ann. Intern. Med. 165 (8): 533–542. doi:10.7326/M16-0547. PMC 5453639. PMID 27479926.
  12. 12.0 12.1 Nieman LK (September 2010). "Approach to the patient with an adrenal incidentaloma". J. Clin. Endocrinol. Metab. 95 (9): 4106–13. doi:10.1210/jc.2010-0457. PMC 2936073. PMID 20823463.
  13. Li B, Guo Q, Yang H, Guan J (January 2013). "Giant non-functional adrenal adenoma: A case report". Oncol Lett. 5 (1): 378–380. doi:10.3892/ol.2012.978. PMC 3525484. PMID 23255953.
  14. Libé R (2015). "Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment". Front Cell Dev Biol. 3: 45. doi:10.3389/fcell.2015.00045. PMC 4490795. PMID 26191527.
  15. 15.00 15.01 15.02 15.03 15.04 15.05 15.06 15.07 15.08 15.09 15.10 15.11 Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T (September 2018). "CT and MRI of adrenal gland pathologies". Quant Imaging Med Surg. 8 (8): 853–875. doi:10.21037/qims.2018.09.13. PMC 6177362. PMID 30306064.
  16. Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (April 2014). "Adrenocortical carcinoma". Endocr. Rev. 35 (2): 282–326. doi:10.1210/er.2013-1029. PMC 3963263. PMID 24423978.
  17. Wang C, Sun Y, Wu H, Zhao D, Chen J (March 2014). "Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers". Histopathology. 64 (4): 567–76. doi:10.1111/his.12283. PMC 4282325. PMID 24102952.
  18. Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM (November 2017). "Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics". Br J Radiol. 90 (1079): 20170330. doi:10.1259/bjr.20170330. PMC 5963387. PMID 28707538. Vancouver style error: name (help)
  19. Zhang Y, Li H (2015). "Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease". Int J Clin Exp Med. 8 (10): 19311–7. PMC 4694469. PMID 26770569.
  20. Martucci VL, Pacak K (2014). "Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment". Curr Probl Cancer. 38 (1): 7–41. doi:10.1016/j.currproblcancer.2014.01.001. PMC 3992879. PMID 24636754.
  21. Kantorovich V, Pacak K (2010). "Pheochromocytoma and paraganglioma". Prog. Brain Res. 182: 343–73. doi:10.1016/S0079-6123(10)82015-1. PMC 4714594. PMID 20541673.
  22. Miller AD, Masek-Hammerman K, Dalecki K, Mansfield KG, Westmoreland SV (November 2009). "Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus)". Vet. Pathol. 46 (6): 1221–9. doi:10.1354/vp.09-VP-0022-M-FL. PMID 19605896.
  23. Kantorovich V, Eisenhofer G, Pacak K (December 2008). "Pheochromocytoma: an endocrine stress mimicking disorder". Ann. N. Y. Acad. Sci. 1148: 462–8. doi:10.1196/annals.1410.081. PMC 2693284. PMID 19120142.
  24. Eisenhofer G, Peitzsch M (December 2014). "Laboratory evaluation of pheochromocytoma and paraganglioma". Clin. Chem. 60 (12): 1486–99. doi:10.1373/clinchem.2014.224832. PMID 25332315.
  25. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG (October 2014). "Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project". J. Clin. Oncol. 32 (28): 3169–76. doi:10.1200/JCO.2014.56.1621. PMC 4171360. PMID 25154816.
  26. Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S (2014). "Epidemiological and clinical characteristics of neuroblastoma in southern iran". Iran J Ped Hematol Oncol. 4 (3): 89–96. PMC 4173027. PMID 25254086.
  27. Skoura E, Oikonomopoulos G, Vasileiou S, Kyprianou D, Koumakis G, Datseris IE (2014). "(18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma". Hell J Nucl Med. 17 (1): 58–61. doi:10.1967/s002449910116. PMID 24563879.
  28. Mylonas KS, Schizas D, Economopoulos KP (October 2017). "Adrenal ganglioneuroma: What you need to know". World J Clin Cases. 5 (10): 373–377. doi:10.12998/wjcc.v5.i10.373. PMC 5648998. PMID 29085827.
  29. Adas M, Koc B, Adas G, Ozulker F, Aydin T (April 2014). "Ganglioneuroma presenting as an adrenal incidentaloma: a case report". J Med Case Rep. 8: 131. doi:10.1186/1752-1947-8-131. PMC 4031973. PMID 24779851.
  30. Li J, Yang CH, Li LM (April 2013). "Diagnosis and treatment of 29 cases of adrenal ganglioneuroma". Eur Rev Med Pharmacol Sci. 17 (8): 1110–3. PMID 23661526.
  31. Lam KY, Lo CY (September 2001). "Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution". J. Clin. Pathol. 54 (9): 707–12. PMC 1731508. PMID 11533079.
  32. Gershuni VM, Bittner JG, Moley JF, Brunt LM (January 2014). "Adrenal myelolipoma: operative indications and outcomes". J Laparoendosc Adv Surg Tech A. 24 (1): 8–12. doi:10.1089/lap.2013.0411. PMC 3931430. PMID 24328509.
  33. Luo J, Chen L, Wen Q, Xu L, Chu S, Wang W, Alnemah MM, Fan S (2015). "Lipoadenoma of the adrenal gland: report of a rare entity and review of literature". Int J Clin Exp Pathol. 8 (8): 9693–7. PMC 4583971. PMID 26464739.
  34. Rodríguez-Gutiérrez R, Rendon A, Barrera-Sánchez M, Carlos-Reyna KE, Álvarez-Villalobos NA, González-Saldivar G, González-González JG (2016). "Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test". Int J Endocrinol. 2016: 9051865. doi:10.1155/2016/9051865. PMC 4781954. PMID 27006656.
  35. Haddara WM, van Uum SH (September 2004). "TB and adrenal insufficiency". CMAJ. 171 (7): 710, author reply 710–1. doi:10.1503/cmaj.1041046. PMC 517840. PMID 15451821.
  36. Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW (October 2015). "Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status". World J Radiol. 7 (10): 336–42. doi:10.4329/wjr.v7.i10.336. PMC 4620114. PMID 26516430.
  37. Vinnard C, Blumberg EA (January 2017). "Endocrine and Metabolic Aspects of Tuberculosis". Microbiol Spectr. 5 (1). doi:10.1128/microbiolspec.TNMI7-0035-2016. PMID 28233510.
  38. Rajasekharan C, Ajithkumar S, Anto V, Parvathy R (May 2013). "Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine". BMJ Case Rep. 2013. doi:10.1136/bcr-2012-008011. PMID 23687365.
  39. Rog CJ, Rosen DG, Gannon FH (December 2016). "Bilateral adrenal histoplasmosis in an immunocompetent man from Texas". Med Mycol Case Rep. 14: 4–7. doi:10.1016/j.mmcr.2016.11.006. PMC 5154969. PMID 27995051.
  40. Wahab NA, Mohd R, Zainudin S, Kamaruddin NA (2013). "Adrenal involvement in histoplasmosis". EXCLI J. 12: 1–4. PMC 4817423. PMID 27047312.
  41. May D, Khaled D, Gills J (July 2018). "Unilateral adrenal histoplasmosis". Urol Case Rep. 19: 54–56. doi:10.1016/j.eucr.2018.03.010. PMC 5991316. PMID 29888193.
  42. Gupta RK, Majumdar K, Srivastava S, Varakanahalli S, Saran RK (2018). "Endoscopic Ultrasound-guided Cytodiagnosis of Adrenal Histoplasmosis with Reversible CD4 T-Lymphocytopenia and Jejunal Lymphangiectasia". J Cytol. 35 (2): 110–113. doi:10.4103/JOC.JOC_234_15. PMC 5885598. PMID 29643659.
  43. Padma S, Sreehar S (May 2014). "18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient". Indian J. Med. Res. 139 (5): 786–7. PMC 4140048. PMID 25027093.
  44. Carsote M, Ghemigian A, Terzea D, Gheorghisan-Galateanu AA, Valea A (2017). "Cystic adrenal lesions: focus on pediatric population (a review)". Clujul Med. 90 (1): 5–12. doi:10.15386/cjmed-677. PMID 28246490.
  45. Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, Kasperlik-Załuska AA (December 2015). "Standards of ultrasound imaging of the adrenal glands". J Ultrason. 15 (63): 377–87. doi:10.15557/JoU.2015.0035. PMC 4710689. PMID 26807295.
  46. Olaoye IO, Adesina MD, Afolayan EA (June 2018). "A giant adrenal cyst with an uncertain preoperative diagnosis causing a dilemma in management". Clin Case Rep. 6 (6): 1074–1076. doi:10.1002/ccr3.1519. PMC 5986023. PMID 29881567.
  47. Hamilton D, Harris MD, Foweraker J, Gresham GA (February 2004). "Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection". J. Clin. Pathol. 57 (2): 208–9. PMC 1770213. PMID 14747454.
  48. Di Serafino M, Severino R, Coppola V, Gioioso M, Rocca R, Lisanti F, Scarano E (September 2017). "Nontraumatic adrenal hemorrhage: the adrenal stress". Radiol Case Rep. 12 (3): 483–487. doi:10.1016/j.radcr.2017.03.020. PMC 5551907. PMID 28828107.
  49. Ierardi AM, Petrillo M, Patella F, Biondetti P, Fumarola EM, Angileri SA, Pesapane F, Pinto A, Dionigi G, Carrafiello G (April 2018). "Interventional radiology of the adrenal glands: current status". Gland Surg. 7 (2): 147–165. doi:10.21037/gs.2018.01.04. PMC 5938278. PMID 29770310.
  50. Alhajri K, Alhasan I, Alzerwi N, Abudaff N (April 2011). "Adrenal haemangioma". BMJ Case Rep. 2011. doi:10.1136/bcr.12.2010.3604. PMC 3079485. PMID 22701011.
  51. Iwamoto G, Shimokihara K, Kawahara T, Takamoto D, Yao M, Teranishi JI, Otani M, Uemura H (2018). "Adrenal Hemangioma: A Case of Retroperitoneal Tumor". Case Rep Med. 2018: 8796327. doi:10.1155/2018/8796327. PMC 5836307. PMID 29560018.
  52. Tarchouli M, Boudhas A, Ratbi MB, Essarghini M, Njoumi N, Sair K, Zentar A (2015). "Giant adrenal hemangioma: Unusual cause of huge abdominal mass". Can Urol Assoc J. 9 (11–12): E834–6. doi:10.5489/cuaj.2967. PMC 4639440. PMID 26600897.
  53. Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F (September 2017). "The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency". Intern. Med. 56 (17): 2261–2269. doi:10.2169/internalmedicine.8216-16. PMC 5635296. PMID 28794358.
  54. Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM (February 2017). "Adrenal lymphoma: presentation, management and prognosis". QJM. 110 (2): 103–109. doi:10.1093/qjmed/hcw174. PMID 27795295.
  55. Karimi F (October 2017). "Primary Adrenal Lymphoma Presenting with Adrenal Failure: A Case Report and Review of the Literature". Int J Endocrinol Metab. 15 (4): e12014. doi:10.5812/ijem.12014. PMC 5750783. PMID 29344029.
  56. Michalopoulos N, Laskou S, Karayannopoulou G, Pavlidis L, Kanellos I (December 2015). "Adrenal Gland Lymphangiomas". Indian J Surg. 77 (Suppl 3): 1334–42. doi:10.1007/s12262-015-1206-y. PMC 4775622. PMID 27011561.
  57. Zhao M, Gu Q, Li C, Yu J, Qi H (2014). "Cystic lymphangioma of adrenal gland: a clinicopathological study of 3 cases and review of literature". Int J Clin Exp Pathol. 7 (8): 5051–6. PMC 4152068. PMID 25197378.
  58. Joliat GR, Melloul E, Djafarrian R, Schmidt S, Fontanella S, Yan P, Demartines N, Halkic N (February 2015). "Cystic lymphangioma of the adrenal gland: report of a case and review of the literature". World J Surg Oncol. 13: 58. doi:10.1186/s12957-015-0490-0. PMC 4335415. PMID 25889625.
  59. Ramakant P, Rana C, Singh KR, Mishra A (2018). "Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management". J Postgrad Med. 64 (2): 112–114. doi:10.4103/jpgm.JPGM_588_16. PMC 5954807. PMID 29067922.
  60. Li S, Li H, Ji Z, Yan W, Zhang Y (November 2015). "Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults". Oncol Lett. 10 (5): 2865–2870. doi:10.3892/ol.2015.3701. PMC 4665718. PMID 26722254.
  61. Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, Ni L, Yang S, Chen Y, Lai Y (October 2018). "Primary adrenal teratoma: A case series and review of the literature". Mol Clin Oncol. 9 (4): 437–442. doi:10.3892/mco.2018.1687. PMC 6125700. PMID 30214733.
  62. Karanikiotis C, Tentes AA, Markakidis S, Vafiadis K (November 2004). "Large bilateral adrenal metastases in non-small cell lung cancer". World J Surg Oncol. 2: 37. doi:10.1186/1477-7819-2-37. PMC 535544. PMID 15541184.
  63. ABRAMS HL, SPIRO R, GOLDSTEIN N (January 1950). "Metastases in carcinoma; analysis of 1000 autopsied cases". Cancer. 3 (1): 74–85. PMID 15405683.
  64. Gerber E, Dinlenc C, Wagner JR (2004). "Laparoscopic adrenalectomy for isolated adrenal metastasis". JSLS. 8 (4): 314–9. PMC 3016821. PMID 15554272.
  65. Vaughan ED (September 1998). "Diagnosis and management of surgical adrenal disorders". Int. J. Urol. 5 (5): 401–17. PMID 9781426.